Research Sample bioBank

Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

Get Weekly Research Sample Updates in your Inbox:

Hepatitis C (HCV) Genotype 1 Clinical Research Samples

Discovery Life Sciences provides the highest quality Hepatitis C (HCV) Genotype 1 Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Hepatitis C (HCV) Genotype 1 Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 272 of 272 total samples
 (0)
Checkout
Advanced Data View:
Showing 272 of 272 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Sample Detail 1Test 2Test Data 2Sample Detail 2Test 3Test Data 3Sample Detail 3Product
Details
Price
Buy
Additional Information 1Additional Data 1Additional Information 2Additional Data 2Additional Detail 2Additional Information 3Additional Data 3Additional Information 4Additional Data 4Additional Detail 4Additional Information 5Additional Data 5Additional Detail 5Additional Information 6Additional Data 6Additional Detail 6Additional Information 7Additional Data 7Additional Detail 7
DLS12-0177Hepatitis C (HCV) Genotype 1ItalySerum1.001.00$95.0055 YFU/A<-70°C19-Jun-12Real-Time PCR183,437 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySurgerySymptomsDepressionAdditional TestingALT: 33 AST: 57 ALP: 122 LDH: 480 Bilirubin: 3.95 Serum Creatinine: 0.62 mg/dL Liver Disease Diagnosis: 2009 Hepatocellular Carcinoma 2012Hepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0367Hepatitis C (HCV) Genotype 1ItalyPlasma1.001.00$95.0078 YMU/A<-70°C27-Jun-12Real-Time PCR86,732 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryDental CareSymptomsFatigueAdditional TestingALT: 22; AST: 23; ALP: 130; Bilirubin: 0.40; Serum Creatinine: 0.90 mg/dL; Liver Disease Diagnosis: 2007; Hepatocellular Carcinoma 2012Hepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0375Hepatitis C (HCV) Genotype 1ItalyPlasma1.001.00$95.0074 YFU/A<-70°C19-Jul-12Real-Time PCR385,711 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySurgery SymptomsFatigue; Jaundice; NauseaAdditional TestingALT: 42; AST: 27; Bilirubin: 0.70; Serum Creatinine: 1.06 mg/dL; Liver Disease Diagnosis: 1989; Hepatic Cirrhosis 2012Hepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0379Hepatitis C (HCV) Genotype 1ItalyPlasma1.001.00$95.0066 YFU/A<-70°C20-Jul-12Real-Time PCR75,041 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySurgery SymptomsFatigue; Abdominal painAdditional TestingALT: 33; AST: 108; ALP: 196; LDH: 437; Bilirubin: 1.72; Serum Creatinine: 0.86 mg/dL; Liver Disease Diagnosis: 2006; Hepatic Cirrhosis 2012Hepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0387Hepatitis C (HCV) Genotype 1ItalyPlasma1.001.00$95.0074 YMU/A<-70°C27-Jul-12Real-Time PCR138,611 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusionSymptomsJoint painAdditional TestingALT: 46; AST: 53; ALP: 126; LDH: 271; Bilirubin: 4.50; Serum Creatinine: 1.56 mg/dL; Liver Disease Diagnosis: 2007; Cirrhosis 2012Hepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0391Hepatitis C (HCV) Genotype 1ItalyPlasma1.001.00$95.0080 YMU/A<-70°C03-Aug-12Real-Time PCR302,904 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; FatigueAdditional TestingALT: 28; AST: 44; ALP: 52; LDH: 549; Bilirubin: 0.66; Serum Creatinine: 1.78 mg/dL; CirrhosisHepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0393Hepatitis C (HCV) Genotype 1ItalyPlasma1.001.00$95.0073 YFU/A<-70°C02-Aug-12Real-Time PCR15,000 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryHousehold Contact; Dental CareSymptomsJoint painAdditional TestingALT: 35; AST: 57; ALP: 95; Bilirubin: 0.65; Serum Creatinine: 0.71 mg/dL; Liver Disease Diagnosis: 1994; Chronic HepatitisHepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0395Hepatitis C (HCV) Genotype 1ItalyPlasma1.002.00$95.0080 YMU/A<-70°C10-Aug-12Real-Time PCR738,478 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryDental CareSymptomsNo symptomsAdditional TestingALT: 41; AST: 80; ALP: 131; LDH: 307; Bilirubin: 0.40; Serum Creatinine: 1.19 mg/dL; Liver Disease Diagnosis: 1997; CirrhosisHepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0398Hepatitis C (HCV) Genotype 1ItalyPlasma1.003.00$95.0042 YMU/A<-70°C04-Sep-12Qiagen RT PCR762,550 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusion; SurgerySymptomsDecreased appetite; Fatigue; Abdominal pain; NauseaAdditional TestingALT: 284; AST: 154; ALP: 79; Bilirubin: 0.68; Serum Creatinine: 0.82 mg/dL; Liver Disease Diagnosis: 2012; Chronic HepatitisHepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0399Hepatitis C (HCV) Genotype 1ItalyPlasma1.003.00$95.0075 YMU/A<-70°C05-Sep-12Real-Time PCR274,773 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsJaundiceAdditional TestingALT: 23; AST: 62; ALP: 116; LDH: 347; Bilirubin: 0.80; Serum Creatinine: 1.151 mg/dL; Liver Disease Diagnosis: 2009; Hepatocellular carcinomaHepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0403Hepatitis C (HCV) Genotype 1ItalyPlasma1.001.00$95.0066 YMWhite<-70°C10-Sep-12Real-Time PCR660,631 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryDental CareSymptomsFatigue; JaundiceAdditional TestingALT: 74; AST: 69; Chronic HepatitisHepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0404Hepatitis C (HCV) Genotype 1ItalyPlasma1.001.00$95.0064 YFWhite<-70°C10-Sep-12Real-Time PCR66,186 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryHousehold ContactSymptomsJaundiceAdditional TestingALT: 71; AST: 39; Chronic HepatitisHepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0405Hepatitis C (HCV) Genotype 1ItalyPlasma1.006.00$95.0078 YMWhite<-70°C10-Sep-12Real-Time PCR104,000 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryDental CareSymptomsJaundice; Joint pain; Sleep disturbancesAdditional TestingALT: 72; AST: 80; Bilirubin: 1.9; Serum Creatinine: 1.0 mg/dL; Chronic HepatitisHepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0406Hepatitis C (HCV) Genotype 1ItalyPlasma1.001.00$95.0080 YMWhite<-70°C11-Sep-12Real-Time PCR807,280 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryDental CareSymptomsDecreased appetite; Fatigue; JaundiceAdditional TestingALT: 107; AST: 37; ALP: 82; LDH: 354; Bilirubin: 0.81; Serum Creatinine: 1.27 mg/dL; Hepatic Cirrhosis Hepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0417Hepatitis C (HCV) Genotype 1ItalyPlasma1.002.00$95.0065 YFWhite<-70°C18-Sep-12Real-Time PCR767,000 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySurgerySymptomsFatigue; Jaundice; NauseaAdditional TestingALT: 184; AST: 187; ALP: 135; Bilirubin: 0.79; Chronic HepatitisHepatitis Serology Resultanti HCV+ (Abbott)
DLS12-0419Hepatitis C (HCV) Genotype 1ItalyPlasma1.002.00$95.0074 YMWhite<-70°C20-Sep-12Real-Time PCR11,900 IU/mLSiemens TruGene HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryDental CareSymptomsJoint painAdditional TestingALT: 161; AST: 144; ALP: 166; LDH: 381; Bilirubin: 0.87; Serum Creatinine: 1.14 mg/dL; Hepatocellular CarcinomaHepatitis Serology Resultanti HCV+ (Abbott)
DLS12-6282Hepatitis C (HCV) Genotype 1USASerum0.251.00$95.0038 YMCuban/Caucasian<-70°C04-Feb-13Roche cobas1,009,903 IU/mLInnogenetics Versant HCV1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySexual TransmissionSymptomsFatigueAdditional TestingALT: 43; AST: 34; ALP: 76; Bilirubin: 0.5Hepatitis SerologyHep C Antibody+; HBsAg-
DLS12-6299Hepatitis C (HCV) Genotype 1RussiaPlasma1.007.00$95.0037 YFWhite<-70°C08-Oct-13Roche cobas6,800,000 IU/mLGenotype1bPer Medical Records$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsAbdominal painAdditional TestingALT: 37; AST: 26; ALP: 72; LDH: 168; Bilirubin: 0.4 mg/dL; Serum Creatinine: 0.71 mg/dL; HAI: Staging 0 Grading 3
DLS12-6300Hepatitis C (HCV) Genotype 1GermanyPlasma1.251.00$95.0051 YMWhite<-70°C11-Oct-13Roche cobas5,500,000 IU/mLGenotype1aPer Medical Records$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySurgerySymptomsNo symptomsAdditional TestingALT: 12; AST: 27; ALP: 39; LDH: 186; Bilirubin: 0.3 mg/dL; Serum Creatinine: 0.79 mg/dL; HAI: Staging 1 Grading 0
DLS12-6349Hepatitis C (HCV) Genotype 1USAPlasma1.251.00$95.0054 YMWhite<-70°C26-Feb-13Roche cobas1,717,375 IU/mLGenotype1aPer Medical Records$95.003-series HepB VaccineYes Is Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryOccupational Working FirefighterSymptomsFatigue; DepressionAdditional TestingALT: 42; AST: 35; ALP: 81; Biopsy: G1 S1
DLS12-7464Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.002.00$40.0045 YMU/A<-70°C16-Jul-11Roche cobas9,704,643 IU/mLHCV Ct Value - 12.3Innogenetics INNO-LIPA1a$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 6.24 (Abbott PRISM)
DLS12-7465Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.004.00$40.0041 YFU/A<-70°C20-Jan-12Roche cobas3,538,653 IU/mLHCV Ct Value - 14Innogenetics INNO-LIPA1a$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 6.19 (Abbott PRISM)
DLS12-7466Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.004.00$40.0044 YFU/A<-70°C03-Mar-12Roche cobas6,270,332 IU/mLHCV Ct Value - 14Innogenetics INNO-LIPA1a$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 9.23 (Abbott PRISM)
DLS12-7467Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.007.00$40.0039 YMU/A<-70°C07-Mar-12Roche cobas916,713 IU/mLHCV Ct Value - 17Innogenetics INNO-LIPA1aImmunoblotC1(4+) C2(4+) E2(3+) NS3(4+) NS4(4+) NS5(-)$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 7.22 (Abbott PRISM)
DLS12-7469Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.005.00$40.0045 YMU/A<-70°C22-Jun-12Roche cobas685,173 IU/mLHCV Ct Value - 15Innogenetics INNO-LIPA1a$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 5.32 (Abbott PRISM)
DLS12-7470Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.008.00$40.0050 YMU/A<-70°C13-Jun-12Roche cobas8,795,263 IU/mLHCV Ct Value - 11Innogenetics INNO-LIPA1a$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 8.09 (Abbott PRISM)
DLS12-7471Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.0012.00$40.0039 YMU/A<-70°C16-Jun-11Roche cobas289,778 IU/mLHCV Ct Value - 11Innogenetics INNO-LIPA1b$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 7.79 (Abbott PRISM)
DLS12-7472Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.009.00$40.0047 YFU/A<-70°C22-Jul-11Roche cobas87,452 IU/mLHCV Ct Value - 23Innogenetics INNO-LIPA1b$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 5.35 (Abbott PRISM)
DLS12-7473Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.0010.00$40.0044 YFU/A<-70°C11-Aug-11Roche cobas665,224 IU/mLHCV Ct Value - 21Innogenetics INNO-LIPA1b$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 5.05 (Abbott PRISM)
DLS12-7474Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.0010.00$40.0035 YMU/A<-70°C20-Jan-12Roche cobas1,289,638 IU/mLHCV Ct Value - 14Innogenetics INNO-LIPA1b$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 6.15 (Abbott PRISM)
DLS12-7475Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.0012.00$40.0043 YMU/A<-70°C28-Jan-12Roche cobas3,951,173 IU/mLHCV Ct Value - 19Innogenetics INNO-LIPA1b$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 7.2 (Abbott PRISM)
DLS12-7476Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.0012.00$40.0062 YFU/A<-70°C23-Apr-12Roche cobas33,879 IU/mLHCV Ct Value - 15Innogenetics INNO-LIPA1b$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 8.33 (Abbott PRISM)
DLS12-7477Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.0010.00$40.0045 YMU/A<-70°C24-Apr-12Roche cobas611,136 IU/mLHCV Ct Value - 19Innogenetics INNO-LIPA1bImmunoblotC1(4+) C2(3+) E2(3+) NS3(3+) NS4(-) NS5(-)$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 5.18 (Abbott PRISM)
DLS12-7479Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.007.00$40.0045 YMU/A<-70°C20-Jun-12Roche cobas4,467,154 IU/mLHCV Ct Value - 15Innogenetics INNO-LIPA1b$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 7.91 (Abbott PRISM)
DLS12-8113Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.002.00$40.0040 YMU/A<-70°C09-Jun-12Roche cobas7,088,335 IU/mLHCV Ct Value - 11Innogenetics INNO-LIPA1b ImmunoblotC1(4+) C2(3+) E2(1+) NS3(4+) NS4(4+) NS5(4+) HBsAg (+) HBV DNA (-)$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 9.03 Abbott PRISM
DLS12-8115Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.0012.00$40.0044 YFU/A<-70°C13-Jul-12Roche cobas2,642,943 IU/mLHCV Ct Value - 11Innogenetics INNO-LIPA1b $40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 7.85 Abbott PRISM
DLS12-8116Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.009.00$40.0054 YMU/A<-70°C28-Jul-12Roche cobas1,204,692 IU/mLHCV Ct Value - 15Innogenetics INNO-LIPA1b ImmunoblotC1(3+) C2(2+) E2(-) NS3(4+) NS4(4+) NS5(2+)$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 6.09 Abbott PRISM
DLS12-8117Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.008.00$40.0047 YMU/A<-70°C18-Aug-12Roche cobas491,061 IU/mLHCV Ct Value - 15Innogenetics INNO-LIPA1a$40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 5.64 Abbott PRISM
DLS12-8118Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.0011.00$40.0044 YMU/A<-70°C25-Aug-12Roche cobas1,179,766 IU/mLHCV Ct Value - 15Innogenetics INNO-LIPA1b $40.00SymptomsAsymptomaticHepatitis SerologyAnti-HCV S/CO - 7.87 Abbott PRISM
DLS12-8349Hepatitis C (HCV) Genotype 1GermanyPlasma1.002.00$95.0039 YMWhite<-70°C13-Mar-13Roche cobas3,400,000 IU/mLResearch Use Only In-House1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusionSymptomsNo symptomsAdditional TestingALT: 90; AST: 49; ALP: 85; Bilirubin: 0.5; Fibroscan 3.7 kPa; Serum Creatinine: 0.9 mg/dLHepatitis SerologyHBcAg-; anti-HBc+; anti-HBs+; anti-HCV+
DLS12-8357Hepatitis C (HCV) Genotype 1GermanyPlasma1.008.00$95.0060 YFWhite<-70°C21-Jan-13Roche cobas380,000 IU/mLResearch Use Only In-House1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsItching; Sleep disturbances; FatigueAdditional TestingALT: 37; AST: 48; ALP: 114; Bilirubin: 0.4; Serum Creatinine: 1.16 mg/dL
DLS12-8359Hepatitis C (HCV) Genotype 1GermanyPlasma0.502.00$95.0051 YFWhite<-70°C01-Feb-13Roche cobas750,000 IU/mLResearch Use Only In-House1b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsAbdominal pain; Fatigue; Sleep disturbances; DepressionAdditional TestingALT: 27.9; AST: 27.2; ALP: 109; LDH: 238; Bilirubin: 0.4; Serum Creatinine: 0.67 mg/dL
DLS12-8492Hepatitis C (HCV) Genotype 1VietnamSerum1.005.00$95.0059 YFAsian<-70°C28-May-13Roche cobas24,000,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Sleep disturbances; NauseaAdditional TestingALT: 12; AST: 50; Bilirubin: 10.8 umol/L; Serum Creatinine: 98 umol/L; Hepatitis C
DLS12-8494Hepatitis C (HCV) Genotype 1VietnamSerum1.001.00$95.0041 YMAsian<-70°C23-Apr-13Roche cobas1,590,000 IU/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Jaundice; Flu-like symptomsAdditional TestingALT: 135; AST: 125; ALP: 107; Bilirubin: 30 umol/L; Serum Creatinine: 66 umol/L Hepatitis SerologyHBsAg- (ECLIA Cobas 6000)
DLS12-8496Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0040 YMAsian<-70°C30-Jul-13Roche cobas460,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission SymptomsNo symptomsAdditional TestingALT: 114 U/L; AST: 73 U/L; Serum Creatinine: 7.3 umol/L Hepatitis SerologyHBsAg+; Anti HCV+ (Elisa)Co-InfectionsHIV+2008
DLS12-8499Hepatitis C (HCV) Genotype 1VietnamSerum1.003.00$95.0058 YMAsian<-70°C05-Jul-13Roche cobas1,160,000 IU/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; FatigueAdditional TestingALT: 24; AST: 95; Bilirubin: 16.1 umol/L Hepatitis SerologyAnti HCV+ (ECLIA Cobas 6000)
DLS12-8501Hepatitis C (HCV) Genotype 1VietnamSerum1.001.00$95.0041 YMAsian<-70°C18-Jul-13Roche cobas22,600,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug Abuse SymptomsFatigue; Joint pain; Sleep disturbancesAdditional TestingALT: 42; AST: 39; Serum Creatinine: 88 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2012
DLS12-8518Hepatitis C (HCV) Genotype 1VietnamPlasma1.008.00$95.0063 YFAsian<-70°C06-May-13Roche cobas978,000 IU/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Sleep disturbancesAdditional TestingALT: 103; AST: 80; Bilirubin: 9.1 umol/L; Serum Creatinine: 89 umol/L Hepatitis SerologyHBsAg- (ECLIA Cobas 6000)
DLS12-8519Hepatitis C (HCV) Genotype 1VietnamPlasma1.0012.00$95.0036 YMAsian<-70°C14-Aug-13Roche cobas35,700,000 IU/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg; Lamivudine 150 mg; Nevirapine 200 mgAcquired Infection CategorySexual Transmission; IV Drug Abuse SymptomsDecreased appetiteAdditional TestingALT: 22 U/L; AST: 41 U/L; Serum Creatinine: 84 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2013
DLS12-8523Hepatitis C (HCV) Genotype 1VietnamPlasma1.0015.00$95.0033 YMAsian<-70°C24-Jul-13Roche cobas45,000,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug Abuse SymptomsDecreased appetite; Fatigue; Sleep disturbancesAdditional TestingALT: 49 U/L; AST: 38 U/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2001
DLS12-8525Hepatitis C (HCV) Genotype 1VietnamPlasma1.0013.00$95.0049 YMAsian<-70°C24-Jul-13Roche cobas17,300,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug Abuse SymptomsFatigueAdditional TestingALT: 85 U/L; AST: 64 U/L; Serum Creatinine: 86 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2012
DLS12-8530Hepatitis C (HCV) Genotype 1VietnamPlasma1.0010.00$95.0037 YMAsian<-70°C15-Jul-13Roche cobas32,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg; Lamivudine 150 mg; Tenofovir 300 mg; Aluvia 200/50 mgAcquired Infection CategorySexual Transmission; IV Drug Abuse SymptomsFatigue; Joint painAdditional TestingALT: 25 U/L; AST: 25 U/L; Serum Creatinine: 103 umol/L Co-InfectionsHIV+2006
DLS13-00016Hepatitis C (HCV) Genotype 1USAPlasma1.001.00$95.0068 YMWhite<-70°C17-Jan-13Method Not Available2,360,000 IU/mLMethod Not Available1a$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesCombivir for HIVAcquired Infection CategorySexual Transmission; IV Drug Abuse SymptomsDecreased appetite; Weight lossAdditional TestingALT: 45; AST: 41; ALP: 80; Bilirubin: 0.4; Serum Creatinine: 0.89 mg/dL; LDH: 89Co-InfectionsHIV+2004
DLS13-00022Hepatitis C (HCV) Genotype 1USASerum0.751.00$95.0053 YMWhite<-70°C04-Oct-12Roche cobasGenMark Dx eSensor XT-81b$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySexual TransmissionSymptomsFatigue; Abdominal pain; Flu-like symptoms; Joint pain; DepressionAdditional TestingALT: 24; AST: 51; Bilirubin: 0.1; Biopsy 7-Jul-2004; Liver Disease Diagnosis: 2003
DLS13-01447Hepatitis C (HCV) Genotype 1USASerum1.001.00$95.0049 YFWhite<-70°C14-Feb-13Quantitative HCV RNA Assay180,965 IU/mLSiemens Trugene HCV1b$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySexual transmission; Rape, SodomizedSymptomsDecreased appetite; Fatigue; Abdominal pain; Flu-like symptoms; Joint pain; Nausea; DepressionAdditional TestingALT: 65; AST: 82 ALP: 148; Bilirubin: 0.61; Serum Creatinine: 0.8 mg/dL
DLS13-01448Hepatitis C (HCV) Genotype 1TaiwanPlasma1.001.00$95.0054 YFAsian<-70°C07-Mar-13Roche cobas111,748 IU/mLRT-PCR, reverse hybridization1b$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsNoneAdditional TestingALT: 31; AST: 32 ALP: 36; Bilirubin: 0.6; Serum Creatinine: 0.8 mg/dL
DLS13-03326Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.008.00$40.0051 YMU/A< -70C02-Jan-12Roche cobas465,532 IU/mLHCV Ct Value - 15Innogenetics INNO-LIPA1aAbbott PRISM6.41 S/CoAnti-HCV$40.00Is Subject on Anti-Viral Therapy / TreatmentNo SymptomsAsymptomatic
DLS13-03330Hepatitis C (HCV) Genotype 1FranceCitrated Plasma1.009.00$40.0038 YMU/A< -70C10-Oct-12Roche cobas344,394 IU/mLHCV Ct Value - 16Innogenetics INNO-LIPA1aAbbott PRISM7.11 S/CoAnti-HCV$40.00Is Subject on Anti-Viral Therapy / TreatmentNo SymptomsAsymptomatic
DLS13-03331Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.008.00$40.0051 YMU/A< -70C29-Jul-07Roche cobas30,508 IU/mLHCV Ct Value - 25Innogenetics INNO-LIPA1aAbbott PRISM5.08 S/CoAnti-HCV$40.00Is Subject on Anti-Viral Therapy / TreatmentNo SymptomsAsymptomatic
DLS13-03333Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.0011.00$40.0048 YMU/A< -70C02-Nov-12Roche cobas377,589 IU/mLHCV Ct Value - 16Innogenetics INNO-LIPA1aAbbott PRISM3.67 S/CoAnti-HCV$40.00Is Subject on Anti-Viral Therapy / TreatmentNo SymptomsAsymptomaticOther Testing ResultsImmunoblot C1(4+) C2(4+) E2(2+) NS3(4+) NS4(4+) NS5(4+)
DLS13-03334Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.0011.00$40.0018 YFU/A< -70C08-Jan-13Roche cobasNot detectedHCV Ct Value - 12Innogenetics INNO-LIPA1aAbbott PRISM6.1 S/CoAnti-HCV$40.00Is Subject on Anti-Viral Therapy / TreatmentNo SymptomsAsymptomatic
DLS13-03335Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.0010.00$40.0049 YMU/A< -70C27-Oct-12Roche cobas538,277 IU/mLHCV Ct Value - 16Innogenetics INNO-LIPA1aAbbott PRISM7.1 S/CoAnti-HCV$40.00Is Subject on Anti-Viral Therapy / TreatmentNo SymptomsAsymptomatic
DLS13-03339Hepatitis C (HCV) Genotype 1SpainCitrated Plasma1.0021.00$40.0026 YFU/A< -70C15-May-10Roche cobas402,570 IU/mLHCV Ct Value - 16Innogenetics INNO-LIPA1aAbbott PRISM7.38 S/CoAnti-HCV$40.00Is Subject on Anti-Viral Therapy / TreatmentNo SymptomsAsymptomaticOther Testing ResultsImmunoblot C100(4+) C33(4+) C22(-) NS5(-)
DLS13-05017Hepatitis C (HCV) Genotype 1VietnamSerum1.007.00$95.0037 YMAsian< -70C28-Jun-13Roche cobas32,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg; Lamivudine 150 mg; Tenofovir 300 mg; Lopinavir / Ritonavir 200 mg / 50 mgAcquired Infection CategorySexual Transmission; IV Drug Abuse SymptomsNo symptomsAdditional TestingALT: 25 U/L; AST: 25 U/L; Serum Creatinine: 103 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2006
DLS13-05031Hepatitis C (HCV) Genotype 1VietnamPlasma1.004.00$95.0032 YMAsian< -70C09-Jul-13Roche cobas2,550,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategoryUnknown SymptomsFatigueAdditional TestingALT: 131; AST: 83; Serum Creatinine: 63 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2012
DLS13-05032Hepatitis C (HCV) Genotype 1VietnamPlasma1.0010.00$95.0036 YMAsian< -70C03-Sep-13Roche cobas1,810,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug Abuse SymptomsNo symptomsAdditional TestingALT: 38; AST: 26 Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2009
DLS13-05033Hepatitis C (HCV) Genotype 1VietnamPlasma1.0013.00$95.0028 YMAsian< -70C17-Sep-13Roche cobas36,200,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission; IV Drug Abuse SymptomsNo symptomsAdditional TestingALT: 78 U/L; AST: 44 U/L; Serum Creatinine: 66 umol/L Hepatitis SerologyHBsAg+; Anti HCV+ (Elisa)Co-InfectionsHIV+2012
DLS13-05034Hepatitis C (HCV) Genotype 1VietnamPlasma1.0017.00$95.0031 YFAsian< -70C28-Aug-13Roche cobas842,000 IU/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; FatigueAdditional TestingALT: 237 U/L; AST: 168 U/L; Bilirubin: 20 umol/L; Serum Creatinine: 70 umol/L Hepatitis SerologyHBsAg-; HIV- (ECLIA Cobas 6000)
DLS13-05036Hepatitis C (HCV) Genotype 1VietnamPlasma1.0014.00$95.0062 YFAsian< -70C20-Jun-13Roche cobas17,000 IU/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; FatigueAdditional TestingALT: 140; AST: 39 Hepatitis SerologyAnti HCV+ (Cobas 6000) / (Elisa)
DLS13-05037Hepatitis C (HCV) Genotype 1VietnamPlasma1.0013.00$95.0030 YMAsian< -70C22-Aug-13Roche cobas13,100,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug Abuse SymptomsFatigueAdditional TestingALT: 22 U/L; AST: 25 U/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2011
DLS13-05038Hepatitis C (HCV) Genotype 1VietnamPlasma1.0012.00$95.0040 YMAsian< -70C13-Sep-13Roche cobas73,500 copies/mLReal-Time PCR1$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg; Lamivudine 150 mg; Nevirapine 200 mgAcquired Infection CategoryIV Drug Abuse SymptomsDecreased appetite; FatigueAdditional TestingALT: 36 U/L; AST: 40 U/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2011
DLS13-05041Hepatitis C (HCV) Genotype 1VietnamPlasma1.005.00$95.0032 YMAsian< -70C10-Jul-13Roche cobas60,700,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission; IV Drug Abuse SymptomsFatigue; Abdominal pain; Joint painAdditional TestingALT: 51; AST: 42; Serum Creatinine: 74 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2013
DLS13-05044Hepatitis C (HCV) Genotype 1VietnamPlasma1.0012.00$95.0044 YMAsian< -70C31-Jul-13Roche cobas17,200,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission SymptomsNo symptomsAdditional TestingALT: 175 U/L; AST: 74 U/L; Serum Creatinine: 105 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2008
DLS13-05046Hepatitis C (HCV) Genotype 1VietnamPlasma1.0018.00$95.0034 YMAsian< -70C12-Sep-13Roche cobas44,000,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission; IV Drug Abuse SymptomsDecreased appetite; FatigueAdditional TestingALT: 93 U/L; AST: 64 U/L Co-InfectionsHIV+2013
DLS13-05047Hepatitis C (HCV) Genotype 1VietnamPlasma1.006.00$95.0031 YFAsian< -70C31-Jul-13Roche cobas3,220,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission SymptomsDecreased appetite; FatigueAdditional TestingALT: 26 U/L; AST: 34 U/L; Serum Creatinine: 65 umol/L Hepatitis SerologyHBsAg+; Anti HCV+ (Elisa)Co-InfectionsHIV+2007
DLS13-05048Hepatitis C (HCV) Genotype 1VietnamPlasma1.0019.00$95.0027 YMAsian< -70C05-Aug-13Roche cobas63,500,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg; Lamivudine 150 mg;Nevirapine 200 mgAcquired Infection CategoryIV Drug Abuse SymptomsDecreased appetite; FatigueAdditional TestingALT: 57 U/L; AST: 33 U/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2010
DLS13-05049Hepatitis C (HCV) Genotype 1VietnamSerum1.008.00$95.0037 YMAsian< -70C10-Sep-13Roche cobas11,700,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Aluvia 200/50 mgAcquired Infection CategoryIV Drug Abuse SymptomsNo symptomsAdditional TestingALT: 118 U/L; AST: 64 U/L; Serum Creatinine: 88 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+1998
DLS13-05055Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0039 YMAsian< -70C27-Jun-13Roche cobas7,170,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySexual Transmission; IV Drug Abuse SymptomsDecreased appetite; Sleep disturbancesAdditional TestingALT: 106 U/L; AST: 61 U/L; Serum Creatinine: 83 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2006
DLS13-05056Hepatitis C (HCV) Genotype 1VietnamSerum1.008.00$95.0037 YMAsian< -70C26-Jul-13Roche cobas10,800,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission; IV Drug Abuse SymptomsDecreased appetite; FatigueAdditional TestingALT: 72 U/L; AST: 48 U/L; Serum Creatinine: 91 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2011
DLS13-05058Hepatitis C (HCV) Genotype 1VietnamSerum1.001.00$95.0034 YMAsian< -70C24-Jul-13Roche cobas21,800,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug Abuse SymptomsDecreased appetite; Fatigue; Jaundice; Weight lossAdditional TestingALT: 20; AST: 11; Bilirubin: 5.7 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2013
DLS13-05059Hepatitis C (HCV) Genotype 1VietnamSerum1.002.00$95.0042 YMAsian< -70C19-Jun-13Roche cobas31,500,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySexual Transmission; IV Drug Abuse SymptomsFatigueAdditional TestingALT: 67; AST: 97Hepatitis SerologyHBsAg-; Anti HCV+Co-InfectionsHIV+2012
DLS13-05066Hepatitis C (HCV) Genotype 1VietnamSerum1.0015.00$95.0040 YMAsian< -70C22-Jul-13Roche cobas16,200,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg; Lamivudine 150 mg;Nevirapine 200 mgAcquired Infection CategoryIV Drug Abuse SymptomsFatigueAdditional TestingALT: 47 U/L; AST: 24 U/L; Serum Creatinine: 76 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2007
DLS13-05068Hepatitis C (HCV) Genotype 1VietnamSerum1.005.00$95.0031 YMAsian< -70C14-Jun-13Roche cobas4,200,000 IU/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; FatigueAdditional TestingALT: 33; AST: 19; Bilirubin: 4.7 umol/L
DLS13-05844Hepatitis C (HCV) Genotype 1VietnamSerum1.009.00$95.0037 YMAsian< -70C13-Nov-13Roche cobas11,700,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; Fatigue; Jaundice; Flu-like symptoms; NauseaAdditional TestingALT: 521 U/L; AST: 480 U/L; Bilirubin: 97.7 umol/L; Serum Creatinine: 93 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)
DLS13-05847Hepatitis C (HCV) Genotype 1VietnamSerum1.008.00$95.0050 YMAsian< -70C06-Dec-13Roche cobas9,870 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; FatigueAdditional TestingALT: 220 U/L; AST: 82 U/L; ALP: 96 U/L; Bilirubin: 55 umol/L; Serum Creatinine: 89 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (ECLIA Cobas 6000)
DLS13-09599Hepatitis C (HCV) Genotype 1VietnamSerum1.005.00$95.0047 YMAsian< -70C23-Dec-13Roche cobas50,000 IU/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusion SymptomsDecreased appetite; Fatigue; DiabetesAdditional TestingALT: 592 U/L; AST: 209 U/L; Bilirubin: 15 umol/L; Serum Creatinine: 71 umol/L
DLS13-09601Hepatitis C (HCV) Genotype 1VietnamSerum1.0018.00$95.0037 YMAsian< -70C13-Nov-13Roche cobas1,570,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; JaundiceAdditional TestingALT: 213 U/L; AST: 84 U/L; Bilirubin: 78 umol/L; Serum Creatinine: 93 umol/L Hepatitis SerologyHBsAg- (ECLIA Cobas 6000)
DLS13-09604Hepatitis C (HCV) Genotype 1VietnamSerum1.0010.00$95.0039 YMAsian< -70C22-Nov-13Roche cobas2,090,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission; IV Drug AbuseSymptomsNo symptomsAdditional TestingALT: 67 U/L; AST: 33 U/L; Serum Creatinine: 86 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2008
DLS13-09607Hepatitis C (HCV) Genotype 1VietnamSerum1.007.00$95.0037 YMAsian< -70C19-Dec-13Roche cobas58,000 IU/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; FatigueAdditional TestingALT: 98 U/L; AST: 48 U/L; Bilirubin: 7.7 umol/L; Serum Creatinine: 89 umol/L Hepatitis SerologyHBsAg-; Anti HCV+ (ECLIA Cobas 6000)
DLS13-09643Hepatitis C (HCV) Genotype 1VietnamPlasma1.007.00$95.0036 YMAsian< -70C27-Dec-13Roche cobas19,100 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg;Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug Abuse SymptomsAsymptomaticAdditional TestingALT: 118 U/L; AST: 71 U/L; Serum Creatinine: 58 umol/L Hepatitis SerologyHBsAg+; Anti HCV+ (Elisa)Co-InfectionsHIV+2010
DLS14-05319Hepatitis C (HCV) Genotype 1VietnamSerum1.006.00$95.0056 YFAsian< -70C10-Jul-14Roche HCV Monitor1,150,000 IU/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; FatigueAdditional TestingALT: 199; AST: 241; Bilirubin: 11.3 umol/L; Serum Creatinine: 0.8 mg/dL
DLS14-05321Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0043 YMAsian< -70C13-Jun-14Roche HCV Monitor2,600,000 IU/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsAbdominal pain; Sleep disturbancesAdditional TestingALT: 114; AST: 132; Bilirubin: 65 umol/L; Serum Creatinine: 1.12 mg/dLHepatitis SerologyAnti HCV+ (Elisa)Co-InfectionsNone
DLS14-05333Hepatitis C (HCV) Genotype 1VietnamSerum1.0019.00$95.0054 YMAsian< -70C13-May-14Roche cobas9,320 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; DepressionAdditional TestingALT: 172; AST: 149; Bilirubin: 18.1 umol/L; Serum Creatinine: 0.77 mg/dL; ALP: 105
DLS14-05334Hepatitis C (HCV) Genotype 1VietnamSerum1.008.00$95.0057 YFAsian< -70C12-May-14Roche cobas1,160 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Abdominal pain; Jaundice; Sleep disturbancesAdditional TestingALT: 597; AST: 444; LDH: 294; Bilirubin: 199.6 umol/L; Serum Creatinine: 0.68 mg/dL
DLS14-05336Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0063 YMAsian< -70C25-Mar-14Roche cobas705,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; DepressionAdditional TestingALT: 122 U/L; AST: 191 U/L
DLS14-05340Hepatitis C (HCV) Genotype 1VietnamSerum1.009.00$95.0062 YFAsian< -70C13-May-14Roche cobas1,300,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Sleep disturbancesAdditional TestingALT: 113; AST: 119; ALP: 61; Bilirubin: 15.7 umol/L; Serum Creatinine: 0.8 mg/dL
DLS14-05341Hepatitis C (HCV) Genotype 1VietnamSerum1.006.00$95.0040 YMAsian< -70C16-Apr-14Roche cobas55,200,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Abdominal pain; Jaundice Additional TestingALT: 1435; AST: 2679; Bilirubin: 185.7 umol/L; Serum Creatinine: 1.0 mg/dL; Hepatitis C
DLS14-05347Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0058 YMAsian< -70C19-Mar-14Roche cobas225,000 copies/mLHCVReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Abdominal pain; Jaundice; Sleep disturbancesAdditional TestingALT: 46; AST: 15; Bilirubin: 38.1 umol/L; Serum Creatinine: 1.0 mg/dLCo-InfectionsHBV+2010
DLS14-05369Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0052 YFAsian< -70C10-Apr-14Roche cobas52,200,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusion SymptomsDecreased appetite; Fatigue; Sleep disturbancesAdditional TestingALT: 1102 U/L; AST: 1037 U/L; Bilirubin: 18 umol/L
DLS14-05372Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0058 YFAsian< -70C13-Jun-14Eppendorf Real Time PCR6,250,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsFatigue; Jaundice Additional TestingALT: 282; AST: 478; Bilirubin: 43.3 umol/L; Serum Creatinine: 0.97 mg/dL
DLS14-05373Hepatitis C (HCV) Genotype 1VietnamSerum1.006.00$95.0064 YFAsian< -70C29-Apr-14Roche cobas1,920,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsAbdominal pain; JaundiceAdditional TestingALT: 149; AST: 437; Bilirubin: 74.2 umol/L; Serum Creatinine: 58 umol/LHepatitis SerologyAnti HCV+Co-InfectionsNone
DLS14-05377Hepatitis C (HCV) Genotype 1VietnamSerum1.009.00$95.0059 YFAsian< -70C22-Jul-14Roche HCV Monitor4,960,000 IU/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; JaundiceAdditional TestingALT: 104; AST: 52; Bilirubin: 11 umol/L; Serum Creatinine: 0.8 mg/dL
DLS14-05379Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0033 YMAsian< -70C22-Apr-14Roche cobas9,020,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Abdominal pain; Sleep disturbances
DLS14-05381Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0037 YMAsian< -70C13-Jun-14Roche cobas10,600,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission; IV Drug AbuseSymptomsNo symptomsAdditional TestingALT: 71; AST: 52; Serum Creatinine: 92 umol/LHepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2003
DLS14-05382Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0035 YMAsian< -70C12-Jun-14Roche cobas25,200,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug Abuse SymptomsNo symptomsAdditional TestingALT: 103; AST: 113Hepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2011
DLS14-05385Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0067 YMAsian< -70C13-Jun-14Roche HCV Monitor1,510,000 IU/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsFatigue; Abdominal pain; Sleep disturbancesAdditional TestingALT: 66; AST: 103; ALP: 102; Bilirubin: 15.3 umol/L; Serum Creatinine: 0.67 mg/dLHepatitis SerologyAnti HCV+ (Elisa)Co-InfectionsNone
DLS14-05395Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0056 YFAsian< -70C13-May-14Roche cobas77,200,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySexual Transmission; IV Drug AbuseSymptomsDecreased appetite; Fatigue; Itching; Sleep disturbancesAdditional TestingALT: 127; AST: 261; ALP: 88; Bilirubin: 14.3 umol/L; Serum Creatinine: 0.8 mg/dL
DLS14-05396Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0039 YMAsian< -70C22-May-14Roche cobas452,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission SymptomsNo symptomsAdditional TestingALT: 156; AST: 20; Bilirubin: 8.3 umol/LHepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2011
DLS14-05410Hepatitis C (HCV) Genotype 1VietnamSerum1.006.00$95.0052 YFAsian< -70C10-Jul-14Roche HCV Monitor2,850,000 IU/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Abdominal pain; JaundiceAdditional TestingALT: 343; AST: 610; Bilirubin: 95.8 umol/L; Serum Creatinine: 0.66 mg/dL
DLS14-05411Hepatitis C (HCV) Genotype 1VietnamSerum1.002.00$95.0064 YFAsian< -70C06-May-14Roche cobas2,700,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Itching; Sleep disturbances; DepressionAdditional TestingALT: 160; AST: 72; Serum Creatinine: 0.6 mg/dL
DLS14-05413Hepatitis C (HCV) Genotype 1VietnamSerum1.006.00$95.0045 YMAsian< -70C05-May-14Roche cobas1,810,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesAbcarvir 300 mg Lamivudine 150 mg Efavirenz 600 mgAcquired Infection CategorySexual Transmission; IV Drug AbuseSymptomsNo symptomsAdditional TestingALT: 51; AST: 66; Serum Creatinine: 131 umol/LHepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2002
DLS14-05415Hepatitis C (HCV) Genotype 1VietnamSerum1.0010.00$95.0049 YMAsian< -70C21-May-14Roche cobas15,500,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug Abuse SymptomsNo symptomsAdditional TestingALT: 44; AST: 36; Serum Creatinine: 75 umol/LHepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+2009
DLS14-05416Hepatitis C (HCV) Genotype 1VietnamSerum1.009.00$95.0032 YMAsian< -70C11-Jun-14Roche cobas2,140,000 copies/mLReal-Time PCR1$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Aluvia 200/50 mgAcquired Infection CategoryIV Drug Abuse SymptomsNo symptomsAdditional TestingALT: 58; AST: 49; Serum Creatinine: 94 umol/LHepatitis SerologyHBsAg-; Anti HCV+ (Elisa)Co-InfectionsHIV+1999
DLS12-0197Hepatitis C (HCV) Genotype 1ItalySerum1.006.00$95.0032 YMWhite< -70C21-Nov-12Roche cobas3,280,000 IU/mL23-Aug-12Siemens TreGene HCV1a2006$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug AbuseSymptomsAbdominal Pain, NauseaAdditional TestingALT: 90; AST: 43; ALP: 172; Bilirubin: 0.44; Liver Disease Diagnosis: Chronic Hepatitis23-Aug-12Hepatitis Serology Resultanti HCV+ (Abbott)2006
DLS12-8271Hepatitis C (HCV) Genotype 1USAPlasma1.0010.00$95.0037 YMHispanic< -70C12-Dec-12Roche cobas1,009,903 IU/mL11-Jun-12Genotype12005; Test Method Unvailable$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesPegylated Interferon; Ribavirin & TelaprevirAcquired Infection CategorySurgery; TransfusionSymptomsFatigueAdditional TestingALT: 50; AST: 32; ALP: 60; Bilirubin: 0.5; Serum Creatinine: 0.92 mg/dL; Biopsy: S2 (Jan-2005); Liver Disease Diagnosis: G1 S07-Jun-12; Jan-2012Hepatitis Serology ResultHCV RNA PCR Pos (11-Jun-2012); HCV RNA PCR Pos (23-Feb-2012); HCV RNA PCR Neg (19-Jan-2012); HCV RNA PCR Neg (12-Jan-2012)
DLS13-02034Hepatitis C (HCV) Genotype 1USASerum1.009.00$95.0066 YMWhite< -70C09-Apr-13Test Method Unavailable860,881 IU/mL1-Sep-12Genotype1bTest Method Unavailable$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug AbuseSymptomsDecreased Appetite; Fatigue; ItchingAdditional TestingALT: 255; AST: 165; ALP: 73; LDH: 165; Bilirubin: 11.2; Serum Creatinine: 0.9 mg/dL; (Biopsy: G2 S2 Jan-2008)15-Aug-12
DLS12-6289Hepatitis C (HCV) Genotype 1GermanyPlasma1.0013.00$95.0077 YFWhite< -70C11-Nov-14Roche cobas1,000,000 IU/mL11-Sep-14Sequencing In-house Assay1b11-Sep-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsN/AAdditional TestingALT: 44.8; AST: 40.8; ALP: 55; LDH: 273; Bilirubin: 1.7 mg/dL; Serum Creatinine: 0.69 mg/dL11-Sep-14
DLS12-6290Hepatitis C (HCV) Genotype 1GermanyPlasma1.002.00$95.0064 YMWhite< -70C11-Sep-14Roche cobas15,000,000 IU/mL4-Sep-14Genotype1aTest Method Unavailable$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug AbuseSymptomsN/AAdditional TestingALT: 138; AST: 82; ALP: 74; LDH: 207; Bilirubin: 0.5 mg/dL; Serum Creatinine: 1.08 mg/dL; Fibroscan 14.1 kPa; (Biopsy F2 Mar-2006)3-Sep-14
DLS14-05328Hepatitis C (HCV) Genotype 1VietnamSerum1.007.00$95.0036 YMAsian< -70C20-Jul-14Roche cobas3,360,000 IU/mL16-Jul-14Real-Time PCR114-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug AbuseSymptomsNo symptomsHepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)16-Jul-2014
DLS14-05339Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0036 YMAsian< -70C10-Sep-14Roche cobas67,900 IU/mL5-Sep-14Real-Time PCR113-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; FatigueAdditional TestingALT: 44; AST: 116; Bilirubin: 7.2 umol/L; Serum Creatinine: 1.1 mg/dL28-Aug-14Hepatitis Serology Result
DLS14-05342Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.75$95.0026 YMAsian< -70C15-Aug-14Roche cobas1,170,000 IU/mL15-Aug-14Real-Time PCR114-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug AbuseSymptomsDecreased appetite; Fatigue; Abdominal pain Hepatitis Serology Result
DLS14-05352Hepatitis C (HCV) Genotype 1VietnamSerum1.0010.00$95.0054 YFAsian< -70C01-Aug-14Roche cobas96,000 copies/mL16-Jul-14Real-Time PCR114-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; Abdominal painAdditional TestingALT: 254; AST: 583 16-Jul-14Hepatitis Serology Result
DLS14-05359Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0044 YMAsian< -70C08-Sep-14Roche cobas900,000 IU/mL5-Sep-14Real-Time PCR114-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; FatigueAdditional TestingALT: 53; AST: 18; Bilirubin: 5.6 umol/L; Serum Creatinine: 1.08 mg/dL28-Aug-14Hepatitis Serology Result
DLS14-05361Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0045 YMAsian< -70C03-Oct-14Roche cobas4,020,000 copies/mL17-Sep-14Real-Time PCR113-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesZidovudine 300 mg; Lamivudine 150 mg; Nevirapine 200 mgAcquired Infection CategorySexual Transmission; IV Drug AbuseSymptomsDecreased appetite; FatigueAdditional TestingALT: 1046; AST: 647; 11-Sep-14Hepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)27-Sep-10; 5-Oct-2010Co-InfectionsHIV+27-Sep-10
DLS14-05365Hepatitis C (HCV) Genotype 1VietnamSerum1.0010.00$95.0035 YMAsian< -70C06-Oct-14Roche cobas11,500 copies/mL4-Sep-14Real-Time PCR113-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission; IV Drug AbuseSymptomsDecreased appetite; FatigueAdditional TestingALT: 181; AST: 129; Serum Creatinine: 92 umol/L4-Jun-14Hepatitis Serology ResultCo-InfectionsHIV+18-Apr-14
DLS14-05370Hepatitis C (HCV) Genotype 1VietnamSerum1.008.00$95.0041 YMAsian< -70C30-Jun-14Roche cobas1,750,000 copies/mL26-Jun-14Real-Time PCR17-Jul-14$95.003-series HepB VaccinePartialIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mgAcquired Infection CategorySexual TransmissionSymptomsNo symptomsAdditional TestingALT: 77; AST: 74; Serum Creatinine: 105 umol/L27-May-14Hepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)27-May-2014Co-InfectionsHIV+16-May-14
DLS14-05374Hepatitis C (HCV) Genotype 1VietnamSerum1.005.00$95.0031 YMAsian< -70C18-Aug-14Roche cobas7,070 IU/mL21-May-14Real-Time PCR114-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusionSymptomsDecreased appetite; Fatigue; JaundiceAdditional TestingALT: 20; AST: 30; Serum Creatinine: 1.08 mg/dL 13-May-14Hepatitis Serology ResultAnti HCV +13-May-2014
DLS14-05383Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0043 YMAsian< -70C14-May-14Roche cobas12,700 copies/mL6-May-14Real-Time PCR122-May-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategorySexual Transmission; IV Drug AbuseSymptomsNo symptomsAdditional TestingALT: 52; AST: 51; Serum Creatinine: 98 umol/L3-Apr-14Hepatitis Serology ResultHBsAg +; Anti HCV + (Elisa)2-Apr-2013Co-InfectionsHIV+2-Apr-13
DLS14-05390Hepatitis C (HCV) Genotype 1VietnamSerum1.0015.00$95.0049 YFAsian< -70C24-Sep-14Roche cobas1,800,000 IU/mL17-Sep-14Real-Time PCR113-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; Fatigue; Abdominal pain Additional TestingALT: 176; AST: 162; Bilirubin: 15.3 umol/L; Serum Creatinine: 0.7 mg/dL22-Sep-14Hepatitis Serology Result
DLS14-05391Hepatitis C (HCV) Genotype 1VietnamSerum1.0016.00$95.0041 YMAsian< -70C31-Jul-14Roche cobas53,300 IU/mL25-Jun-14Real-Time PCR114-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsFatigue; JaundiceHepatitis Serology ResultHBsAg +; Anti HCV + (Elisa)20-Jun-2014
DLS14-05394Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0058 YFAsian< -70C29-Jul-14Roche cobas4,200,000 copies/mL18-Jul-14Real-Time PCR114-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsFatigueAdditional TestingALT: 54; AST: 60; ALP: 61; Bilirubin: 10 umol/L; Serum Creatinine: 67 umol/L12-Jul-14Hepatitis Serology Result
DLS14-05398Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0027 YMAsian< -70C15-Jul-14Roche cobas1,700 IU/mL13-Jun-14Real-Time PCR118-Jul-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug AbuseSymptomsDecreased appetite; Fatigue Additional TestingALT: 143; AST: 37; Serum Creatinine: 96 umol/L9-Jul-14Hepatitis Serology ResultHBsAg - (Elisa)15-Jun-2014
DLS14-05399Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0040 YMAsian< -70C20-Aug-14Roche cobas27,400 IU/mL15-Aug-14Real-Time PCR114-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsFatigue; NauseaAdditional TestingALT: 47; AST: 376-Aug-14Hepatitis Serology Result
DLS14-05400Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0033 YFAsian< -70C18-Aug-14Roche cobas441,000 IU/mL7-Aug-14Real-Time PCR114-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; Fatigue Additional TestingALT: 21; AST: 23; Bilirubin: 8.1 umol/L; Serum Creatinine: 0.67 mg/dL7-Aug-14Hepatitis Serology Result
DLS14-05404Hepatitis C (HCV) Genotype 1VietnamSerum1.006.00$95.0045 YMAsian< -70C02-Oct-14Roche cobas13,700,000 copies/mL11-Sep-14Real-Time PCR113-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug AbuseSymptomsFatigue; Abdominal painAdditional TestingALT: 44; AST: 813-Sep-14Hepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)10-Jan-2007Co-InfectionsHIV+15-Jun-06
DLS14-05412Hepatitis C (HCV) Genotype 1VietnamSerum1.0010.00$95.0037 YFAsian< -70C25-Aug-14Roche cobas2,900 IU/mL19-Aug-14Real-Time PCR114-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; Fatigue Additional TestingALT: 19; AST: 1419-Aug-14Hepatitis Serology ResultAnti HCV + (Elisa)28-Aug-2014
DLS14-07965Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0064 YMAsian< -70C25-Sep-14Roche cobas17,300 IU/mL24-Sep-14Real-Time PCR113-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; Fatigue Additional TestingALT: 77 U/L; AST: 58 U/L; Bilirubin: 7.8 umol/L; Serum Creatinine: 1.0 mg/dL10-Sep-14
DLS14-07966Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0035 YMAsian< -70C13-Oct-14Roche cobas40,800 IU/mL25-Sep-14Real-Time PCR114-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; Fatigue; Sleep disturbances Additional TestingALT: 61 U/L; AST: 78 U/L; Bilirubin: 9.8 umol/L; Serum Creatinine: 0.9 mg/dL3-Oct-14
DLS14-08034Hepatitis C (HCV) Genotype 1VietnamSerum1.0015.00$95.0041 YMAsian< -70C05-Nov-14Roche cobas187,000 copies/mL10-Jul-14Real-Time PCR114-Nov-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsFatigueAdditional TestingALT: 97 U/L; AST: 122 U/L; Serum Creatinine: 66 umol/L7-Jun-14Hepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)20-Jun-2010
DLS14-08040Hepatitis C (HCV) Genotype 1VietnamSerum1.0010.00$95.0053 YFAsian< -70C28-Oct-14Roche cobas131,000 IU/mL14-Oct-14Real-Time PCR129-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySexual TransmissionSymptomsFatigue; ItchingAdditional TestingALT: 274 U/L; AST: 223 U/L14-Oct-14Hepatitis Serology ResultAnti HCV + (Elisa)14-Oct-2014
DLS14-08044Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0035 YMAsian< -70C07-Nov-14Roche cobas51,200,000 copies/mL26-Aug-14Real-Time PCR114-Nov-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 150 mg; Aluvia 200/50 mgAcquired Infection CategoryIV Drug AbuseSymptomsNo symptomsAdditional TestingALT: 69 U/L; AST: 47 U/L21-Aug-14Hepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)21-Aug-2014Co-InfectionsHIV + 1-Jul-03
DLS14-08046Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0035 YMAsian< -70C10-Nov-14Roche cobas3,550,000 copies/mL10-Sep-14Real-Time PCR114-Nov-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug AbuseSymptomsNo symptomsAdditional TestingALT: 48 U/L; AST: 69 U/L20-Aug-14Hepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)17-Jul-2013; 30-Jul-2013Co-InfectionsHIV + 17-Jul-13
DLS14-08052Hepatitis C (HCV) Genotype 1VietnamSerum1.0016.00$95.0038 YMAsian< -70C24-Sep-14Roche cobas6,220,000 IU/mL16-Sep-14Real-Time PCR113-Oct-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsDecreased appetite; Fatigue Additional TestingALT: 49 U/L; AST: 85 U/L; Bilirubin: 8.0 umol/L; Serum Creatinine: 1.0 mg/dL11-Sep-14
DLS14-07962Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0031 YMAsian< -70C13-Jan-15Roche cobas5,920,000 copies/mL6-Jan-15Real-Time PCR121-Jan-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategorySexual TransmissionSymptomsNo symptomsAdditional TestingALT: 89 U/L; AST: 38 U/L; Serum Creatinine: 89 umol/L6-Jan-15Hepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)6-Jan-2015Co-Infections
DLS14-07974Hepatitis C (HCV) Genotype 1VietnamSerum1.006.00$95.0037 YMAsian< -70C03-Dec-14Roche cobas712,000 copies/mL30-Oct-14Real-Time PCR14-Dec-14$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mgAcquired Infection CategoryUnknownSymptomsDecreased Appetite; FatigueAdditional TestingALT: 30 U/L; AST: 100 U/L; Serum Creatinine: 99 umol/L26-Jun-14Hepatitis Serology ResultHBsAG -; Anti HCV + (Elisa)6-Dec-2012
DLS14-08045Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0044 YMAsian< -70C11-Dec-14Roche cobas1,000,000 copies/mL27-Nov-14Real-Time PCR116-Dec-14$95.003-series HepB VaccinenoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug AbuseSymptomsFatigue; ItchingAdditional TestingALT: 37 U/L; AST: 124 U/L; Serum Creatinine: 62 umol/dL27-Nov-14Hepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)14-May-2008Co-InfectionsHIV Positive1-Jul-08
DLS14-08047Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0065 YMAsian< -70C29-Jan-15Roche cobas75,600 IU/mL23-Jan-15Real-Time PCR14-Feb-15$95.003-series HepB VaccinePartialIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknownSymptomsFatigue; JaundiceAdditional TestingALT: 150 U/L; AST: 120 U/L; Bilirubin: 20.5 umol/L; Serum Creatinine: 85 umol/dL20-Jan-15Hepatitis Serology ResultNone
DLS14-08055Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0039 YMAsian< -70C15-Jan-15Roche cobas5,050,000 copies/mL3-Dec-14Real-Time PCR122-Jan-15$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mgAcquired Infection CategoryIV Drug AbuseSymptomsJoint pain; Sleep DisturbancesAdditional TestingALT: 101 U/L; AST: 110 U/L; Serum Creatinine: 74 umol/L17-Nov-14Hepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)4-Aug-2011Co-InfectionsHIV Positive1-Jul-01
DLS14-07976Hepatitis C (HCV) Genotype 1VietnamSerum1.004.00$95.0048 YMAsian<-70C02-Apr-15Roche cobas69,000,000 IU/mL27-Mar-15Real-Time PCR18-Apr-15$95.003-series HepB VaccinePartialIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsFatigue; JaundiceAdditional TestingALT: 827 U/L; AST: 320 U/L; Bilirubin: 299 umol/L; Serum Creatinine: 79 umol/L 31-Mar-15Hepatitis Serology ResultNone
DLS14-08004Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0038 YMAsian<-70C02-Mar-15Roche cobas82,500 copies/mL5-Nov-14Real-Time PCR113-Mar-15$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesAcquired Infection CategoryIV Drug AbuseSymptomsFatigue; Abdominal PainAdditional TestingALT: 66 U/L; AST: 87 U/L27-Oct-14Hepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)15-Mar-11
DLS14-08025Hepatitis C (HCV) Genotype 1VietnamSerum1.0016.00$95.0037 YMAsian<-70C13-May-15Roche cobas4,900 copies/mL28-Jan-15Real-Time PCR113-Mar-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesAcquired Infection CategoryIV Drug AbuseSymptomsNo symptomsAdditional TestingALT: 25 U/L; AST: 90 U/L; Serum Creatinine: 99 umol/L 14-Aug-14Hepatitis Serology ResultHBsAg -; Anti HCV + (Elisa)20-Jan-14
DLS14-07981Hepatitis C (HCV) Genotype 1VietnamSerum1.0010.00$95.0041 YMAsian<-70C14-May-15Roche cobas888,000 IU/mL6-Mar-15Real-Time PCR121-May-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsNo symptoms
DLS14-08017Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0035 YMAsian<-70C27-May-15Roche cobas1,940,000 copies/mL23-Apr-15Real-Time PCR19-Jul-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir 300 mg, Lamivudine 150 mg, Efavirenz 600 mgAcquired Infection CategorySexual transmission , IV Drug AbuseSymptomsNo symptoms
DLS14-08028Hepatitis C (HCV) Genotype 1VietnamSerum1.005.00$95.0040 YMAsian<-70C12-Aug-15Roche cobas52,000,000 copies/mL5-May-15Real-Time PCR120-Aug-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsNo symptoms
DLS14-08029Hepatitis C (HCV) Genotype 1VietnamSerum1.009.00$95.0056 YMAsian<-70C21-Jul-15Roche cobas3,900,000 IU/mL16-Jul-15Real-Time PCR17-Aug-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue
DLS14-21184Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0038 YMAsian<-70C28-Aug-15Roche cobas15,200,000 IU/mL13-Aug-15Real-Time PCR13-Sep-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite
DLS14-21223Hepatitis C (HCV) Genotype 1VietnamSerum1.009.00$95.0029 YMAsian<-70C01-Sep-15Roche cobas11,300,000 IU/mL20-Aug-15Real-Time PCR13-Sep-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug Abuse SymptomsFatigue
DLS14-21235Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0043 YFAsian<-70C18-Aug-15Roche cobas16,700,000 IU/mL6-Aug-15Real-Time PCR120-Aug-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsFatigue; Nausea
DLS14-21236Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0057 YFAsian<-70C01-Sep-15Roche cobas14,900,000 IU/mL19-Aug-15Real-Time PCR13-Sep-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue
DLS14-21243Hepatitis C (HCV) Genotype 1VietnamSerum1.009.00$95.0061 YFAsian<-70C21-Jul-15Roche cobas5,690,000 IU/mL16-Jul-15Real-Time PCR17-Aug-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsFatigue
DLS14-21245Hepatitis C (HCV) Genotype 1VietnamSerum1.0010.00$95.0065 YFAsian<-70C08-Sep-15Roche cobas8,950,000 IU/mL4-Sep-15Real-Time PCR110-Sep-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue
DLS14-21248Hepatitis C (HCV) Genotype 1VietnamSerum1.0015.00$95.0036 YMAsian<-70C07-Sep-15Roche cobas9,000,000 copies/mL3-Jul-15Real-Time PCR110-Sep-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug Abuse SymptomsFatigue
DLS14-21260Hepatitis C (HCV) Genotype 1VietnamSerum1.0010.00$95.0056 YMAsian<-70C07-Sep-15Roche cobas5,990 copies/mL1-Sep-15Real-Time PCR110-Sep-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsFatigue
DLS14-21276Hepatitis C (HCV) Genotype 1VietnamSerum1.009.00$95.0031 YMAsian<-70C08-Sep-15Roche cobas695,000 IU/mL4-Sep-15Real-Time PCR110-Sep-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Jaundice
DLS14-21187Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0020 YMAsian<-70C17-Sep-15Real-Time PCR118-Sep-15$95.00Signs and SymptomsDecreased appetite
DLS14-21189Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0038 YMAsian<-70C30-Sep-15Real-Time PCR11-Oct-15$95.00Signs and SymptomsNo symptoms
DLS14-21198Hepatitis C (HCV) Genotype 1VietnamSerum1.0016.00$95.0039 YMAsian<-70C04-Nov-15Real-Time PCR111-Nov-15$95.00Signs and SymptomsFatigue; Nausea; GI bleeding
DLS14-21204Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0069 YFAsian<-70C01-Oct-15Roche cobas1,680,000 IU/mL30-Sep-15Real-Time PCR18-Oct-15$95.00Signs and SymptomsDecreased appetite; Fatigue
DLS14-21216Hepatitis C (HCV) Genotype 1VietnamSerum1.0015.00$95.0033 YMAsian<-70C15-Dec-15Real-Time PCR116-Dec-15$95.00Signs and SymptomsNo symptomsCo-InfectionsHIV Positive13-Oct-15
DLS14-21224Hepatitis C (HCV) Genotype 1VietnamSerum1.0010.00$95.0043 YMAsian<-70C26-Oct-15Roche cobas5,720,000 IU/mL9-Oct-15Real-Time PCR15-Nov-15$95.00Signs and SymptomsDecreased appetite; FatigueCo-InfectionsHIV Positive8-Feb-10
DLS14-21230Hepatitis C (HCV) Genotype 1VietnamSerum1.007.00$95.0066 YMAsian<-70C09-Dec-15Roche cobas1,820,000 IU/mL3-Dec-15Real-Time PCR116-Dec-15$95.00Signs and SymptomsFatigue; Abdominal pain
DLS14-21250Hepatitis C (HCV) Genotype 1VietnamSerum1.008.00$95.0025 YMAsian<-70C16-Oct-15Roche cobas412,000 IU/mL28-Sep-15Real-Time PCR119-Nov-15$95.00Signs and SymptomsNo symptomsCo-InfectionsHIV Positive18-Apr-14
DLS14-21262Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0029 YMAsian<-70C18-Sep-15Real-Time PCR124-Sep-15$95.00Signs and SymptomsNo symptomsCo-InfectionsHIV Positive5-Jul-13
DLS14-21275Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0051 YMAsian<-70C06-Oct-15Roche cobas5,890,000 IU/mL24-Sep-15Real-Time PCR18-Oct-15$95.00Signs and Symptoms Fatigue
DLS14-21280Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0057 YFAsian<-70C02-Oct-15Real-Time PCR18-Oct-15$95.00Signs and Symptoms Fatigue; Fever; Cough
DLS14-21282Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0070 YFAsian<-70C10-Sep-15Roche cobas11,720,000 IU/mL8-Sep-15Real-Time PCR117-Sep-15$95.00Signs and SymptomsFatigue; Nausea
DLS16-67368Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0057 YMAsian<-70C07-Nov-16Roche cobas7,230,000 IU/mL4-Nov-16Real-Time PCR19-Nov-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Abdominal painAdditional TestingALT: 309 U/L; AST: 931 U/L; Bilirubin: 15.5 umol/L; Serum Creatinine: 95 umol/L2-Nov-16Hepatitis SerologyHCV Ab + (Architect plus cobas)28-Oct-16Co-InfectionsN/A
DLS16-67372Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0040 YFAsian<-70C29-Sep-16Roche cobas1,880,000 IU/mL28-Sep-16Real-Time PCR13-Oct-16$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite Additional TestingALT: 143 U/L; AST: 176 U/L; Bilirubin: 13.8 umol/L; Serum Creatinine: 72 umol/L22-Sep-16Hepatitis SerologyN/ACo-InfectionsN/A
DLS16-67374Hepatitis C (HCV) Genotype 1VietnamSerum1.0019.00$95.0033 YMAsian<-70C27-Sep-16Roche cobas338,000 IU/mL23-Sep-16Real-Time PCR129-Sep-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusion SymptomsDecreased appetite; Fatigue; ItchingAdditional TestingALT: 76 U/L; AST: 345 U/L; Bilirubin: 10.2 umol/L; Serum Creatinine: 1153 umol/L20-Sep-16Hepatitis SerologyN/ACo-InfectionsN/A
DLS16-67403Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0035 YMAsian<-70C01-Nov-16Roche cobas837,000 IU/mL26-Oct-16Real-Time PCR13-Nov-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Sleep disturbancesAdditional TestingALT: 186 U/L; AST: 602 U/L; Bilirubin: 82.5 umol/L; Serum Creatinine: 74 umol/L31-Oct-16Hepatitis SerologyHCV Ab + (cobas 6000E)Oct-16Co-InfectionsN/A
DLS16-67411Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0054 YFAsian<-70C25-Oct-16Roche cobas195,000 IU/mL24-Oct-16Real-Time PCR129-Oct-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Abdominal pain; ItchingAdditional TestingALT: 84 U/L; AST: 168 U/L; Bilirubin: 16.2 umol/L; Serum Creatinine: 74 umol/L5-Oct-16Hepatitis SerologyHCV Ab + (cobas 6000E)5-Oct-16Co-InfectionsN/A
DLS16-67432Hepatitis C (HCV) Genotype 1VietnamSerum1.0015.00$95.0048 YFAsian<-70C13-Oct-16Roche cobas9,800 IU/mL11-Oct-16Real-Time PCR117-Oct-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Abdominal painAdditional TestingALT: 34 U/L; AST: 47 U/L; Bilirubin: 12.1 umol/L; Serum Creatinine: 68 umol/L6-Oct-16Hepatitis SerologyN/ACo-InfectionsN/A
DLS16-67434Hepatitis C (HCV) Genotype 1VietnamSerum1.0017.00$95.0042 YMAsian<-70C23-Sep-16Roche cobas6,800 IU/mL23-Sep-16Real-Time PCR129-Sep-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug Abuse SymptomsDecreased appetite; Fatigue Additional TestingALT: 166 U/L; AST: 276 U/L; Bilirubin: 55.1 umol/L; Serum Creatinine: 77 umol/L21-Sep-16Hepatitis SerologyN/ACo-InfectionsHIV+2006
DLS16-67437Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0040 YMAsian<-70C06-Oct-16Roche cobas1,460,000 IU/mL4-Oct-16Real-Time PCR110-Oct-16$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue Additional TestingALT: 39 U/L; AST: 86 U/L; Serum Creatinine: 76 umol/L28-Sep-16Hepatitis SerologyN/ACo-InfectionsN/A
DLS16-67454Hepatitis C (HCV) Genotype 1VietnamSerum1.0020.00$95.0061 YMAsian<-70C27-Sep-16Roche cobas217,000 IU/mL26-Sep-16Real-Time PCR129-Sep-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue Additional TestingALT: 45 U/L; AST: 5 U/L; 42621; Serum Creatinine: 172 umol/L23-Sep-16Hepatitis SerologyN/ACo-InfectionsN/A
DLS16-67457Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0043 YMAsian<-70C13-Oct-16Roche cobas178,000 IU/mL11-Oct-16Real-Time PCR117-Oct-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Abdominal painAdditional TestingALT: 121 U/L; AST: 133 U/L; Bilirubin: 9.4 umol/L; Serum Creatinine: 97 umol/L6-Oct-16Hepatitis SerologyN/ACo-InfectionsN/A
DLS16-67460Hepatitis C (HCV) Genotype 1VietnamSerum1.0015.00$95.0044 YFAsian<-70C08-Nov-16Roche cobas21,200 IU/mL2-Nov-16Real-Time PCR110-Nov-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue Additional TestingALT: 41 U/L; AST: 65 U/L; Bilirubin: 11.5 umol/L; Serum Creatinine: 63 umol/L28-Oct-16Hepatitis SerologyN/ACo-InfectionsN/A
DLS16-67465Hepatitis C (HCV) Genotype 1VietnamSerum1.0015.00$95.0030 YMAsian<-70C21-Nov-16Roche HCV Monitor11,300,000 copies/mL15-Nov-16Real-Time PCR122-Nov-16$95.003-series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir; Lamivudine; EfavirenzAcquired Infection CategorySexual transmission SymptomsNo symptomsAdditional TestingALT: 68 U/L; AST: 110 U/L; Serum Creatinine: 90 umol/L13-Oct-16Hepatitis SerologyN/ACo-InfectionsHIV+12-Apr-16
DLS16-67476Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0058 YMAsian<-70C30-Nov-16Roche cobas270,000 IU/mL28-Nov-16Real-Time PCR11-Dec-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsFatigue; Abdominal painAdditional TestingALT: 85 U/L; AST: 88 U/L; Bilirubin: 49.2 umol/L; Serum Creatinine: 83 umol/L27-Nov-16Hepatitis SerologyHCV Ab + (cobas 6000E)21-Nov-16Co-InfectionsN/A
DLS16-67500Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0034 YMAsian<-70C14-Nov-16Roche HCV Monitor44,000,000 copies/mL25-Nov-16Real-Time PCR116-Nov-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug Abuse SymptomsFatigueAdditional TestingALT: 14 U/L; AST: 29 U/L; Serum Creatinine: 87 umol/L13-Oct-16Hepatitis SerologyN/ACo-InfectionsHIV+13-Oct-15
DLS16-67502Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0043 YMAsian<-70C21-Nov-16Roche cobas7,710,000 copies/mL20-Nov-16Real-Time PCR122-Nov-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir; Lamivudine; EfavirenzAcquired Infection CategoryIV Drug Abuse SymptomsNo symptomsAdditional TestingALT: 71 U/L; AST: 55 U/L; Serum Creatinine: 92 umol/L19-May-16Hepatitis SerologyN/ACo-InfectionsHIV+10-Aug-10
DLS16-67578Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0041 YFAsian<-70C29-Nov-16Roche cobas2,160,000 IU/mL24-Nov-16Real-Time PCR11-Dec-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue; Sleep disturbancesAdditional TestingALT: 117 U/L; AST: 251 U/L; Bilirubin: 15.4 umol/L; Serum Creatinine: 61 umol/L25-Nov-16Hepatitis SerologyHCV Ab + (cobas 6000E)21-Nov-16Co-InfectionsN/A
DLS16-67659Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0038 YMAsian<-70C15-Nov-16Roche HCV Monitor2,060,000 copies/mL13-Nov-16Real-Time PCR116-Nov-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug Abuse SymptomsFatigueAdditional TestingALT: 111 U/L; AST: 65 U/L; Serum Creatinine: 82 umol/L; Biopsy Result: (F1 (6 kPa); 25-Dec-2014)14-Sep-16Hepatitis SerologyN/ACo-InfectionsHIV+31-Dec-14
DLS16-67785Hepatitis C (HCV) Genotype 1VietnamSerum1.0016.00$95.0035 YMAsian<-70C17-Nov-16Roche HCV Monitor2,990,000 copies/mL15-Nov-16Real-Time PCR118-Nov-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryIV Drug Abuse SymptomsNo symptomsAdditional TestingALT: 59 U/L; AST: 57 U/L; Serum Creatinine: 94 umol/L; Biopsy Result: (F1; 8-Mar-2016)13-Sep-16Hepatitis SerologyN/ACo-InfectionsHIV+10-Feb-16
DLS16-67471Hepatitis C (HCV) Genotype 1VietnamSerum1.008.00$95.0040 YMAsian<-70C18-Jan-17Roche Cobas10,400,000 IU/mL16-Jan-17$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknown SymptomsFatigueAdditional TestingALT: 54 U/L, AST: 27 U/L, Bilirubin: 62 umol/L, Serum Creatinine: 74 umol/L17-Jan-2017 Hepatitis SerologyNoneCo-InfectionsNone
DLS16-67490Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0039 YFAsian<-70C14-Mar-17Roche Cobas7,640,000 IU/mL10-Mar-17$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknown SymptomsDecreased appetite; FatigueAdditional TestingALT: 535 U/L, AST: 1173 U/L, Bilirubin: 53.4 umol/L, Serum Creatinine: 70 umol/L, HCV 201713-Mar-2017Hepatitis SerologyHCV Ab +Co-InfectionsNone
DLS16-67505Hepatitis C (HCV) Genotype 1VietnamSerum1.0015.00$95.0038 YMAsian<-70C12-Jan-17Roche Cobas1,560,000 copies/mL10-Jan-17$95.003-Series HepB VaccinePartialIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir; Lamivudine; EfavirenzAcquired Infection CategoryIV Drug Abuse SymptomsFatigueAdditional TestingALT: 47 U/L, AST: 157 U/L, Serum Creatinine: 87 umol/L27-Sep-2016 Hepatitis SerologyNoneCo-InfectionsHIV+9-Oct-10
DLS16-67506Hepatitis C (HCV) Genotype 1VietnamSerum1.0015.00$95.0043 YFAsian<-70C30-Dec-16Roche Cobas83,700 IU/mL29-Dec-16$95.003-Series HepB VaccineYesIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknown SymptomsDecreased appetite; Abdominal painAdditional TestingALT: 89 U/L, AST: 123 U/L, Bilirubin: 17.3 umol/L, Serum Creatinine: 74 umol/L, HCV 201422-Dec-2016 Hepatitis SerologyNoneCo-InfectionsNone
DLS16-67537Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0028 YMAsian<-70C07-Feb-17Roche Cobas21,100,000 IU/mL5-Feb-17$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknown SymptomsFatigue; Abdominal painAdditional TestingALT: 128 U/L, AST: 138 U/L, Bilirubin: 21.4 umol/L, Serum Creatinine: 54 umol/L, HCV 20175-Feb-2017 Hepatitis SerologyNoneCo-InfectionsNone
DLS16-67539Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0044 YMAsian<-70C08-Mar-17Roche Cobas2,060,000 copies/mL6-Mar-17$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir; Lamivudine; EfavirenzAcquired Infection CategorySexual TransmissionSymptomsFatigueAdditional TestingALT: 69 U/L, AST: 120 U/L , Serum Creatinine: 103 umol/L26-Dec-2016 Hepatitis SerologyNoneCo-InfectionsHIV+12-Nov-12
DLS16-67587Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0039 YFAsian<-70C01-Dec-16Roche Cobas4,450,000 IU/mL29-Nov-16$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir; Lamivudine; EfavirenzAcquired Infection CategorySexual TransmissionSymptomsFatigueAdditional TestingALT: 37 U/L, AST: 29 U/L, Serum Creatinine: 62 umol/L24-Nov-2016Hepatitis SerologyNoneCo-InfectionsHIV+19-Mar-14
DLS16-67588Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0075 YMAsian<-70C11-Jan-17Roche Cobas13,800 copies/mL9-Jan-17$95.003-Series HepB VaccinePartialIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknown SymptomsFatigueAdditional TestingALT: 110 U/L, AST: 90 U/L4-Jan-2017Hepatitis SerologyNoneCo-InfectionsNone
DLS16-67597Hepatitis C (HCV) Genotype 1VietnamSerum1.0010.00$95.0049 YFAsian<-70C02-Mar-17Roche Cobas2,100,000 IU/mL1-Mar-17$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknown SymptomsDecreased appetite; FatigueAdditional TestingALT: 206 U/L, AST: 260 U/L, Serum Creatinine: 97 umol/LHCV, 201727-Feb-2017Hepatitis SerologyNoneCo-InfectionsNone
DLS16-67600Hepatitis C (HCV) Genotype 1VietnamSerum1.0010.00$95.0058 YMAsian<-70C05-Dec-16Roche Cobas95,000 IU/mL4-Dec-16$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategorySexual TransmissionSymptomsFatigueAdditional TestingALT: 120 U/L, AST: 81 U/L23-Nov-2016Hepatitis SerologyNoneCo-InfectionsNone
DLS16-67602Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0033 YFAsian<-70C27-Dec-16Roche Cobas436,000 copies/mL26-Dec-16$95.003-Series HepB VaccinePartialIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir; Lamivudine; EfavirenzAcquired Infection CategorySexual TransmissionSymptomsFatigueAdditional TestingALT: 102 U/L, AST: 61 U/L, Serum Creatinine: 62 umol/L15-Dec-2016Hepatitis SerologyNoneCo-InfectionsHIV+4-Dec-13
DLS16-67604Hepatitis C (HCV) Genotype 1VietnamSerum1.009.00$95.0034 YFAsian<-70C29-Mar-17Roche Cobas8,260,000 IU/mL27-Mar-17$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknown SymptomsFatigue; Abdominal painAdditional TestingALT: 46 U/L, AST: 51 U/L, Bilirubin: 17.6 umol/L, Serum Creatinine: 63 umol/L, Chronic HCV 201020-Mar-2017 Hepatitis SerologyHCV Ab +Co-InfectionsAIDS+2010
DLS16-67620Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0037 YMAsian<-70C22-Dec-16Roche Cobas210,000 IU/mL21-Dec-16$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir; Lamivudine; EfavirenzAcquired Infection CategoryIV Drug Abuse SymptomsFatigue; Abdominal painAdditional Testing ALT: 43 U/, LAST: 24 U/L, Serum Creatinine: 87 umol/L, HCV 201020-Dec-2016 Hepatitis SerologyNoneCo-InfectionsHIV+19-Aug-10
DLS16-67622Hepatitis C (HCV) Genotype 1VietnamSerum1.008.00$95.0067 YMAsian<-70C09-Dec-16Roche Cobas162,000 IU/mL8-Dec-16$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue Additional TestingALT: 72 U/L, AST: 84 U/L, Bilirubin: 19 umol/L, Serum Creatinine: 63 umol/L, Chronic HCV 20156-Dec-2016 Hepatitis SerologyNoneCo-InfectionsNone
DLS16-67627Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0041 YMAsian<-70C20-Feb-17Roche Cobas23,000,000 IU/mL18-Feb-17$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknown SymptomsDecreased appetite; Fatigue Additional TestingALT: 32.8 U/L, AST: 24.2 U/L, Serum Creatinine: 77.2 umol/L, Chronic HCV 20157-Feb-2017Hepatitis SerologyHCV Ab +Co-InfectionsNone
DLS16-67632Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0052 YMAsian<-70C16-Dec-16Roche Cobas170,000 IU/mL15-Dec-16$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknown SymptomsFatigueAdditional TestingALT: 82 U/L, AST: 63 U/L, Chronic HCV 201515-Dec-2016Hepatitis SerologyNoneCo-InfectionsNone
DLS16-67642Hepatitis C (HCV) Genotype 1VietnamSerum1.0013.00$95.0042 YMAsian<-70C08-Dec-16Roche Cobas30,600,000 copies/mL6-Dec-16$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir; Lamivudine; EfavirenzAcquired Infection CategorySexual TransmissionSymptomsFatigueAdditional TestingALT: 12 U/L, AST: 46 U/L, Serum Creatinine: 128 umol/L26-Sep-2016Hepatitis SerologyNoneCo-InfectionsHIV+15-Oct-10
DLS16-67649Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0034 YMAsian<-70C23-Feb-17Roche Cobas910,000 IU/mL21-Feb-17$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentYesTenofovir; Lamivudine; EfavirenzAcquired Infection CategoryIV Drug Abuse SymptomsFatigueAdditional TestingALT: 61 U/L, AST: 41 U/L, Bilirubin: 45 umol/L, Serum Creatinine: 74 umol/L, Chronic HCV 201420-Feb-2017Hepatitis SerologyNoneCo-InfectionsHIV+17-Jul-14
DLS16-67653Hepatitis C (HCV) Genotype 1VietnamSerum1.009.00$95.0046 YFAsian<-70C12-Apr-17Roche Cobas26,000,000 IU/mL12-Apr-17$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknown SymptomsJaundice; Fatigue; Abdominal painAdditional TestingALT: 1276 U/L, AST: 98 U/L, Bilirubin: 127 umol/L, Serum Creatinine: 82 umol/L, HCV 9-Apr-201710-Apr-2017Hepatitis SerologyHCV Ab +Co-InfectionsNone
DLS16-67782Hepatitis C (HCV) Genotype 1VietnamSerum1.008.00$95.0048 YMAsian<-70C05-Apr-17Roche Cobas590,000 IU/mL2-Apr-17$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoNoneAcquired Infection CategoryUnknown SymptomsDecreased appetite; Depression; Fatigue; JaundiceAdditional TestingALT: 101 U/LAST: 173 U/L Bilirubin: 12.6 umol/LSerum Creatinine: 89 umol/LChronic HCV Mar-201729-Mar-2017Hepatitis SerologyHCV Ab +Co-InfectionsNone
DLS16-67509Hepatitis C (HCV) Genotype 1VietnamSerum1.0015.00$95.0057 YMAsian<-70C26-Apr-17Roche Cobas736,000 IU/mL26-Apr-17Real Time PCR128-Apr-173-series HepB VaccineNo$95.00Is Subject on Anti-Viral Therapy / TreatmentNoneAcquired Infection CategoryU/ASymptomsFatigueAdditional TestingALT: 72 U/L | AST: 64 U/L | Bilirubin: 62 umol/L | Serum Creatinine: 54 umol/L25-Apr-17Hepatitis SerologyHCV Ab + | COBAS 6000E3-Jul-1905Co-InfectionsNone
DLS16-67507Hepatitis C (HCV) Genotype 1VietnamSerum1.0016.00$95.0057 YMAsian<-70C27-Apr-17Roche Cobas6,690 IU/mL27-Apr-17Real Time PCR128-Apr-173-series HepB VaccineNo$95.00Is Subject on Anti-Viral Therapy / TreatmentNoneAcquired Infection CategoryU/ASymptomsFatigue; JaundiceAdditional TestingALT: 91 U/L | AST: 90 U/L | Bilirubin: 22 umol/L | Serum Creatinine: 73 umol/L26-Apr-17Hepatitis SerologyNoneCo-InfectionsNone
DLS16-67508Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0035 YMAsian<-70C27-Apr-17Roche Cobas2,050,000 IU/mL27-Apr-17Real Time PCR128-Apr-173-series HepB VaccineNo$95.00Is Subject on Anti-Viral Therapy / TreatmentNoneAcquired Infection CategoryIV Drug AbuseSymptomsItching; Unexplained weight loss; FatigueAdditional TestingALT: 32 U/L | AST: 45 U/L | Bilirubin: 21 umol/L | Serum Creatinine: 73 umol/L22-Apr-17Hepatitis SerologyNoneCo-InfectionsNone
DLS16-67598Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0042 YMAsian<-70C27-Apr-17Roche Cobas12,100,000 IU/mL27-Apr-17Real Time PCR15-May-173-series HepB VaccineYes$95.00Is Subject on Anti-Viral Therapy / TreatmentNoneAcquired Infection CategoryIV Drug AbuseSymptomsItching; DepressionAdditional TestingALT: 68 U/L | AST: 42 U/L | Bilirubin: 14.2 umol/L | Serum Creatinine: 62 umol/L26-Mar-17Hepatitis SerologyNoneCo-InfectionsHIV+ | 1-Jul-2005 | CD4 - 190 15-Sep-2016
DLS16-67516Hepatitis C (HCV) Genotype 1VietnamSerum1.0018.00$95.0063 YMAsian<-70C10-May-17Roche Cobas30,300,000 IU/mL10-May-17Real Time PCR115-May-173-series HepB VaccineNo$95.00Is Subject on Anti-Viral Therapy / TreatmentNoneAcquired Infection CategoryU/ASymptomsFatigue; JaundiceAdditional TestingALT: 111 U/L | AST: 214 U/L | Bilirubin: 18.4 umol/L | Serum Creatinine: 78 umol/L5-May-17Hepatitis SerologyHCV Ab + | COBAS 6000E4-May-2017Co-InfectionsNone
DLS16-67555Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0035 YMAsian<-70C15-May-17Roche Cobas50,100 IU/mL25-May-17Real Time PCR123-May-173-series HepB VaccineNo$95.00Is Subject on Anti-Viral Therapy / TreatmentNoneAcquired Infection CategoryU/ASymptomsDecreased appetite; Fatigue; Abdominal pain; Itching; Sleep disturbancesAdditional TestingALT: 36 U/L | AST: 52 U/L | Bilirubin: 12 umol/L | Serum Creatinine: 76 umol/L4-May-17Hepatitis SerologyHCV Ab + | COBAS 6000ECo-InfectionsNone
DLS16-67647Hepatitis C (HCV) Genotype 1VietnamSerum1.0014.00$95.0039 YMAsian<-70C18-May-17Roche Cobas3,260,000 IU/mL18-May-17Real Time PCR125-May-173-series HepB Vaccineno$95.00Is Subject on Anti-Viral Therapy / TreatmentNoneAcquired Infection CategoryU/ASymptomsDecreased appetite; Abdominal pain; Night sweats; Dark urine; Fatigue; Sleep disturbancesAdditional TestingALT: 52 U/L | AST: 37 U/L | Serum Creatinine: 74 umol/L12-May-17Hepatitis SerologyHCV Ab + | COBAS 6000E 12-May-2017 Co-InfectionsNone
DLS16-67530Hepatitis C (HCV) Genotype 1VietnamSerum1.0011.00$95.0038 YMAsian<-70C22-May-17Roche Cobas5,000,000 IU/mL22-May-17Real Time PCR125-May-173-series HepB VaccineNo$95.00Is Subject on Anti-Viral Therapy / TreatmentNoneAcquired Infection CategoryU/ASymptomsItching; Night sweats; Unexplained weight loss; Fatigue; Flu-like symptomsAdditional TestingALT: 26 U/L | AST: 37 U/L | Bilirubin: 12 umol/L | Serum Creatinine: 73 umol/L12-May-17Hepatitis SerologyNoneCo-InfectionsNone
DLS16-67526Hepatitis C (HCV) Genotype 1VietnamSerum1.0012.00$95.0043 YMAsian<-70C22-May-17Roche Cobas11,600,000 IU/mL22-May-17Real Time PCR125-May-173-series HepB VaccineYes$95.00Is Subject on Anti-Viral Therapy / TreatmentNoneAcquired Infection CategoryIV Drug AbuseSymptomsFatigue; JaundiceAdditional TestingALT: 45 U/L | AST: 34 U/L | Serum Creatinine: 114 umol/L8-May-17Hepatitis SerologyNoneCo-InfectionsNone
DLS16-67464Hepatitis C (HCV) Genotype 1VietnamSerum1.0017.00$95.0032 YFAsian<-70C23-Jun-17Roche Cobas260,000 IU/mL23-Jun-17Real Time PCR120-Jun-173-series HepB VaccineNo$95.00Is Subject on Anti-Viral Therapy / TreatmentNoneAcquired Infection CategoryU/ASymptomsAbdominal pain; FatigueAdditional TestingALT: 48 U/L | AST: 82 U/L | Bilirubin: 28 umol/L | Serum Creatinine: 62 umol/L20-Jun-17Hepatitis SerologyNoneCo-InfectionsNone
DLS16-67570Hepatitis C (HCV) Genotype 1VietnamSerum1.0010.00$95.0047 YMAsian<-70C22-Jun-17Roche Cobas5,000,000 IU/mL22-Jun-17Real Time PCR126-Jun-173-series HepB VaccineNo$95.00Is Subject on Anti-Viral Therapy / TreatmentNoneAcquired Infection CategoryU/ASymptomsFatigue; JaundiceAdditional TestingALT: 68 U/L | AST: 72 U/L22-Jun-17Hepatitis SerologyHCV Ab + | COBAS 6000E18-Jun-2017Co-InfectionsNone
DLS16-72214Hepatitis C (HCV) Genotype 1ItalySerum1.0013.00$95.0051 YFWhite<-70C14-Nov-17Roche cobas579,000 IU/mL14-Jul-17Siemens TruGene HCV 5NC1b14-Jul-17HCV Date of Diagnosis10-Aug-92$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 152 U/L | AST: 40 U/L | 14-Jul-2017 | Bilirubin: 0.36 mg/dL | Serum Creatinine: 0.65 mg/dL | Chronic Hepatitis C14-Nov-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb+, HBcAb-, 15-Nov-17Co-InfectionsNone
DLS16-72183Hepatitis C (HCV) Genotype 1ItalySerum1.0015.00$95.0048 YFWhite<-70C27-Jun-17Roche cobas783,000 IU/mL21-Mar-17Siemens TruGene HCV 5NC1b21-Mar-17HCV Date of Diagnosis1-Feb-94$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 38 U/L | AST: 38 U/L | | Bilirubin: 0.69 mg/dL | Serum Creatinine: 0.86 mg/dL | Chronic Hepatitis C27-Jun-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb-, HBcAb-, 27-Jun-17Co-InfectionsNone
DLS16-72199Hepatitis C (HCV) Genotype 1ItalySerum1.0010.00$95.0072 YFWhite<-70C17-Jul-17Roche cobas148,000 IU/mL8-May-17Siemens TruGene HCV 5NC1b8-May-17HCV Date of Diagnosis9-Mar-97$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsFatigueAdditional TestingALT: 38 U/L | AST: 38 U/L | | Bilirubin: 0.48 mg/dL | Serum Creatinine: 0.7 mg/dL | Chronic Hepatitis C17-Jul-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb-, HBcAb-, 8-May-17Co-InfectionsNone
DLS0025511Hepatitis C (HCV) Genotype 1ItalySerum1.0013.00$95.0041 YMWhite<-70C27-Nov-17Roche cobas650,000 IU/mL6-Sep-17Siemens TruGene HCV 5NC1b1-Sep-15HCV Date of Diagnosis16-Nov-09$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 20 U/L | AST: 28 U/L | Bilirubin: 1.5 mg/dL | Serum Creatinine: 1.04 mg/dL | 13-Jul-2010 | Biopsy | HAI = 7 FIB1 ST3 Chronic Hepatitis C6-Sep-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb+, HBcAb-, 6-Sep-17Co-InfectionsNone
DLS16-72217Hepatitis C (HCV) Genotype 1ItalySerum1.006.00$95.0054 YMWhite<-70C11-Oct-17Roche cobas445,000 IU/mL11-Oct-17Siemens TruGene HCV 5NC1b19-May-10HCV Date of Diagnosis19-Mar-10$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsFatigueAdditional TestingALT: 26 U/L | 28-Mar-2017 | AST: 84 U/L | | Bilirubin: 3.54 mg/dL | Serum Creatinine: 0.7 mg/dL | Liver Cirrhosis from HCV26-Sep-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb-, HBcAb-, 28-Mar-17Co-InfectionsNone
DLS0025504Hepatitis C (HCV) Genotype 1ItalySerum1.006.00$95.0053 YFWhite<-70C27-Nov-17Roche cobas6,780,000 IU/mL8-Sep-17Siemens TruGene HCV 5NC1b8-Sep-17HCV Date of Diagnosis3-Jul-10$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 20 U/L | AST: 30 U/L | Bilirubin: 0.56 mg/dL | Serum Creatinine: 0.71 mg/dL | Chronic Hepatitis C16-Jun-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb+, HBcAb-, HBeAg-, 8-Sep-17Co-InfectionsNone
DLS0025509Hepatitis C (HCV) Genotype 1ItalySerum1.0012.00$95.0052 YFWhite<-70C27-Nov-17Roche cobas880,000 IU/mL13-Oct-17Siemens TruGene HCV 5NC1b13-Oct-17HCV Date of Diagnosis29-Aug-13$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 40 U/L | AST: 24 U/L | Bilirubin: 0.7 mg/dL | Serum Creatinine: 0.7 mg/dL | 29-Aug-2013 | Biopsy HAI = 6 FIB2 Chronic Hepatitis C13-Oct-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb-, HBcAb-, 13-Oct-17Co-InfectionsNone
DLS16-72188Hepatitis C (HCV) Genotype 1ItalySerum1.0014.00$95.0059 YFWhite<-70C20-Sep-17Roche cobas58,500 IU/mL29-Sep-16Siemens TruGene HCV 5NC1b9-Dec-13HCV Date of Diagnosis9-Dec-13$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsFatigueAdditional TestingALT: 50 U/L | AST: 50 U/L | Serum Creatinine: 0.6 mg/dL | Chronic Hepatitis C13-Jul-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb+, HBcAb+, 13-Jul-17Co-InfectionsNone
DLS16-72197Hepatitis C (HCV) Genotype 1ItalySerum1.0014.00$95.0081 YMWhite<-70C18-Oct-17Roche cobas1,200,000 IU/mL16-Oct-17Siemens TruGene HCV 5NC1b16-Oct-16HCV Date of Diagnosis2-Feb-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 56 U/L | AST: 55 U/L | ALP: 56 U/L | Bilirubin: 0.63 mg/dL | Serum Creatinine: 0.99 mg/dL | Chronic Hepatitis C4-Sep-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb-, HBcAb-, 16-Oct-17Co-InfectionsNone
DLS16-72194Hepatitis C (HCV) Genotype 1ItalySerum1.0017.00$95.0076 YMWhite<-70C13-Jul-17Roche cobas606,130 IU/mL2-Sep-16Siemens TruGene HCV 5NC1b11-Jan-17HCV Date of Diagnosis1-Mar-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 36 U/L | AST: 42 U/L | | Bilirubin: 1.8 mg/dL | Serum Creatinine: 0.76 mg/dL | Liver Cirrhosis from HCV13-Jul-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb-, HBcAb+, 5-May-17Co-InfectionsNone
DLS16-72185Hepatitis C (HCV) Genotype 1ItalySerum1.0011.00$95.0068 YFWhite<-70C21-Nov-17Roche cobas6,500,000 IU/mL10-May-17Siemens TruGene HCV 5NC1b11-Mar-15HCV Date of Diagnosis11-Mar-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 44 U/L | AST: 48 U/L | Serum Creatinine: 0.9 mg/dL | Chronic Hepatitis C4-Sep-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb+, HBcAb+, 4-Sep-17Co-InfectionsNone
DLS16-72207Hepatitis C (HCV) Genotype 1ItalySerum1.0011.00$95.0069 YMWhite<-70C27-Sep-17Roche cobas319,000 IU/mL3-May-17Siemens TruGene HCV 5NC1b3-May-17HCV Date of Diagnosis8-May-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 40 U/L | AST: 88 U/L | Bilirubin: 0.51 mg/dL | Serum Creatinine: 1.0 mg/dL | | 3-May-2017 | ALP: 111 U/L | Chronic Hepatitis C27-Sep-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb+, HBcAb+, 3-May-17Co-InfectionsNone
DLS16-72198Hepatitis C (HCV) Genotype 1ItalySerum1.0013.00$95.0050 YFWhite<-70C27-Jul-17Roche cobas3,000,000 IU/mL4-Feb-17Siemens TruGene HCV 5NC1b10-Jun-15HCV Date of Diagnosis10-Jun-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 40 U/L | AST: 38 U/L | | Bilirubin: 0.7 mg/dL | Serum Creatinine: 0.7 mg/dL | Chronic Hepatitis C27-Jul-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb-, HBcAb-, 4-Feb-17Co-InfectionsNone
DLS16-72210Hepatitis C (HCV) Genotype 1ItalySerum1.0014.00$95.0076 YFWhite<-70C25-Oct-17Roche cobas2,120,000 IU/mL1-Sep-17Siemens TruGene HCV 5NC1b1-Oct-17HCV Date of Diagnosis10-Aug-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsFatigueAdditional TestingALT: 42 U/L | AST: 42 U/L | Serum Creatinine: 0.7 mg/dL | 31-Aug-2017 | Bilirubin: 0.5 mg/dL | Chronic Hepatitis C19-Oct-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb-, HBcAb+, 31-Aug-17Co-InfectionsNone
DLS16-72200Hepatitis C (HCV) Genotype 1ItalySerum1.004.00$95.0082 YMWhite<-70C09-Jun-17Roche cobas913,750 IU/mL22-May-17Siemens TruGene HCV 5NC1b22-Sep-15HCV Date of Diagnosis22-Sep-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 100 U/L | AST: 120 U/L | | Bilirubin: 1.2 mg/dL | Serum Creatinine: 1.8 mg/dL | Liver Cirrhosis from HCV22-May-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb-, HBcAb+, 22-May-17Co-InfectionsNone
DLS16-72186Hepatitis C (HCV) Genotype 1ItalySerum1.0013.00$95.0065 YFWhite<-70C27-Jul-17Roche cobas3,700,000 IU/mL10-Feb-17Siemens TruGene HCV 5NC1b23-Feb-16HCV Date of Diagnosis10-Feb-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 40 U/L | AST: 40 U/L | | Bilirubin: 0.7 mg/dL | Serum Creatinine: 0.6 mg/dL | Chronic Hepatitis C20-Jun-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb+, HBcAb-, 23-Feb-17Co-InfectionsNone
DLS16-72216Hepatitis C (HCV) Genotype 1ItalySerum1.0011.00$95.0064 YFWhite<-70C13-Oct-17Roche cobas1,300,000 IU/mL5-Apr-17Siemens TruGene HCV 5NC1b3-May-17HCV Date of Diagnosis16-Jun-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsFatigueAdditional TestingALT: 20 U/L | AST: 35 U/L | 5-Apr-2017 | Bilirubin: 0.7 mg/dL | 29-Sep-2017 | Serum Creatinine: 0.69 mg/dL | 24-Mar-2016 | Biopsy HAI=12 Chronic Hepatitis C13-Oct-17Diasorin Liaison Serology ResultsHBsAg-, HBcAb+ 3-May-17Co-InfectionsNone
DLS16-72189Hepatitis C (HCV) Genotype 1ItalySerum1.0011.00$95.0071 YFWhite<-70C05-Oct-17Roche cobas390,000 IU/mL14-Mar-17Siemens TruGene HCV 5NC1b17-Mar-17HCV Date of Diagnosis14-Mar-17$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 40 U/L | AST: 46 U/L | ALP: 46 U/L | Bilirubin: 1.1 mg/dL | 16-Jan-2017 Serum Creatinine: 0.9 mg/dL | Chronic Hepatitis C31-Aug-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb+, HBcAb+, HBeAb+, 16-Jan-17Co-InfectionsNone
DLS16-72209Hepatitis C (HCV) Genotype 1ItalySerum1.0012.00$95.0055 YFWhite<-70C13-Sep-17Roche cobas654,234 IU/mL24-Apr-17Siemens TruGene HCV 5NC1b24-Apr-17HCV Date of Diagnosis24-Apr-17$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsFatigueAdditional TestingALT: 20 U/L | AST: 24 U/L | | Bilirubin: 1.5 mg/dL | Serum Creatinine: 0.82 mg/dL | Chronic Hepatitis C11-Sep-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb-, HBcAb-, 24-Apr-17Co-InfectionsNone
DLS16-72206Hepatitis C (HCV) Genotype 1ItalySerum1.006.00$95.0073 YFWhite<-70C06-Sep-17Roche cobas965,000 IU/mL7-Jul-17Siemens TruGene HCV 5NC1b7-Jul-17HCV Date of Diagnosis27-Jun-17$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 140 U/L | AST: 96 U/L | Bilirubin: 1.2 mg/dL | Serum Creatinine: 0.69 mg/dL | | 4-Mar-2017 | ALP: 171 U/L | Liver Cirrhosis from Chronic HCV2-Sep-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb+, HBcAb+, 6-Apr-17Co-InfectionsNone
DLS16-72203Hepatitis C (HCV) Genotype 1ItalySerum1.0011.00$95.0069 YFWhite<-70C05-Oct-17Roche cobas3,200,000 IU/mL15-Sep-17Siemens TruGene HCV 5NC1b30-Aug-17HCV Date of Diagnosis26-Jul-17$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 84 U/L | AST: 60 U/L | 3-Jul-2017 | Bilirubin: 0.62 mg/dL | Serum Creatinine: 0.74 mg/dL | Chronic Hepatitis C3-Oct-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb+, HBcAb+, HBeAg-, HBeAb+, 15-Sep-17Co-InfectionsNone
DLS16-72212Hepatitis C (HCV) Genotype 1ItalySerum1.009.00$95.0053 YMWhite<-70C25-Oct-17Roche cobas2,810,000 IU/mL29-Aug-17Siemens TruGene HCV 5NC1b29-Aug-17HCV Date of Diagnosis29-Aug-17$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsFatigueAdditional TestingALT: 32 U/L | AST: 48 U/L | ALP: 51 U/L | Bilirubin: 0.5 mg/dL | Serum Creatinine: 0.6 mg/dL | Chronic Hepatitis C29-Aug-17Diasorin Liaison Serology ResultsHBsAg-, HBcAb+, 29-Aug-17Co-InfectionsNone
DLS0025505Hepatitis C (HCV) Genotype 1ItalySerum1.0011.00$95.0070 YFWhite<-70C27-Nov-17Roche cobas856,000 IU/mL14-Sep-17Siemens TruGene HCV 5NC1b14-Sep-17HCV Date of Diagnosis14-Sep-17$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 35 U/L | AST: 52 U/L | Bilirubin: 0.7 mg/dL | Serum Creatinine: 0.9 mg/dL | Chronic Hepatitis C14-Sep-17Diasorin Liaison Serology ResultsHBsAg-, HBcAb-, 14-Sep-17Co-InfectionsNone
DLS16-72213Hepatitis C (HCV) Genotype 1ItalySerum1.0011.00$95.0076 YFWhite<-70C25-Oct-17Roche cobas1,060,000 IU/mL16-Oct-17Siemens TruGene HCV 5NC1b16-Oct-17HCV Date of Diagnosis16-Oct-17$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNo symptomsAdditional TestingALT: 28 U/L | AST: 52 U/L | Bilirubin: 0.5 mg/dL | Serum Creatinine: 0.8 mg/dL | Chronic Hepatitis C16-Oct-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb-, HBcAb-, 7-Nov-17Co-InfectionsNone
DLS16-72191Hepatitis C (HCV) Genotype 1ItalySerum1.0012.00$95.0059 YMWhite<-70C14-Nov-17Roche cobas10,900,000 IU/mL17-Oct-17Siemens TruGene HCV 5NC1a17-Oct-17HCV Date of Diagnosis17-Oct-17$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsFatigueAdditional TestingALT: 16 U/L | AST: 24 U/L | Bilirubin: 0.5 mg/dL | Serum Creatinine: 0.8 mg/dL | Chronic Hepatitis C17-Oct-17Diasorin Liaison Serology ResultsHBsAg-, HBsAb-, HBcAb-,, HBeAb-, 17-Jul-17Co-InfectionsNone
DLS16-67531Hepatitis C (HCV) Genotype 1VietnamSerum1.0016.00$95.0060 YMAsian<-70°C26-Apr-17Roche Cobas2,990,000 IU/mL26-Apr-2017Real Time PCRGenotype 128-Apr-20173-series HepB VaccineNo$95.00Is Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsFatigue; JaundiceAdditional TestingALT: 62 U/L | AST: 78 U/L | Bilirubin: 62 umol/L | Serum Creatinine: 60 umol/L20-Apr-2017Hepatitis SerologyHCV Ab +27-Apr-2017Co-InfectionsNone
DLS0025506Hepatitis C (HCV) Genotype 1ItalySerum1.0013.00$95.0048 YFWhite<-70C20-Dec-17Roche cobas3,880,000 IU/mLHCV Viral LoadGenotype1b19-Oct-173-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingALT: 35 U/L | AST: 35 U/L | Bilirubin: 0.46 mg/dL | 19-Oct-2017 | Creatinine: 0.6 mg/dL | Chronic Hepatitis C23-Sep-17Hepatitis SerologyHBsAg- | HBsAb- | HBcAb- |HBeAg- (CMIA)19-Oct-17Co-InfectionsNone
DLS0025520Hepatitis C (HCV) Genotype 1ItalySerum1.0010.00$95.0052 YFWhite<-70C20-Dec-17Roche cobas639,000 IU/mLHCV Viral LoadGenotype1a27-Oct-173-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsFatigueAdditional TestingALP: 73 U/L | Bilirubin: 0.72 mg/dL | Creatinine: 1.02 mg/dL | Chronic Hepatitis C27-Oct-17Hepatitis SerologyHBsAg- | HBsAb+ | HBcAb- | (CMIA)27-Oct-17Co-InfectionsNone
DLS0025508Hepatitis C (HCV) Genotype 1ItalySerum1.009.00$95.0064 YFWhite<-70C30-Jan-18Roche cobas17,500,000 IU/mLHCV Viral LoadGenotype1b17-Nov-173-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingALT: 18 U/L | AST: 22 U/L | Bilirubin: 0.7 mg/dL | Creatinine: 0.76 mg/dL | Chronic Hepatitis C8-Nov-17Hepatitis SerologyHBsAg- | 12-Dec-2017 | HBsAb+ | HBcAb+ 17-Nov-2017 (CMIA)Co-InfectionsNone
DLS0025513Hepatitis C (HCV) Genotype 1ItalySerum1.006.00$95.0042 YMWhite<-70C17-Jan-18Roche cobas7,290,000 IU/mLHCV Viral LoadGenotype1b17-Jan-183-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingALT: 110 U/L | AST: 130 U/L | Bilirubin: 0.6 mg/dL | Creatinine: 0.7 mg/dL | Chronic Hepatitis C23-Nov-17Hepatitis SerologyHBsAg- | HBsAb+ | HBcAb- | (CMIA)23-Nov-17Co-InfectionsNone
DLS0025510Hepatitis C (HCV) Genotype 1ItalySerum1.009.00$95.0057 YMWhite<-70C12-Jan-18Roche cobas3,090,000 IU/mLHCV Viral LoadGenotype1b15-Jun-173-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingALT: 100 U/L | AST: 60 U/L | Bilirubin: 0.8 mg/dL | Creatinine: 0.6 mg/dL | Chronic Hepatitis C28-Nov-17Hepatitis SerologyHBsAg- | HBsAb- | HBcAb- | (CMIA)28-Nov-17Co-InfectionsNone
DLS0025502Hepatitis C (HCV) Genotype 1ItalySerum1.0011.00$95.0073 YMWhite<-70C20-Dec-17Roche cobas8,970,000 IU/mLHCV Viral LoadGenotype1b7-Jul-173-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsFatigueAdditional TestingALT: 91 U/L | AST: 55 U/L | Creatinine: 1.04 mg/dL | Chronic Hepatitis C11-Dec-17Hepatitis SerologyHBsAg- | HBsAb+ | HBcAb+ | (CMIA)11-Aug-17Co-InfectionsNone
DLS0025512Hepatitis C (HCV) Genotype 1ItalySerum1.0012.00$95.0045 YFWhite<-70C17-Jan-18Roche cobas61,000 IU/mLHCV Viral LoadGenotype1b21-Dec-173-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingBilirubin: 0.6 mg/dL | Creatinine: 0.4 mg/dL | Chronic Hepatitis C21-Dec-17Hepatitis SerologyHBsAg- | HBsAb- | HBcAb- | (CMIA)21-Dec-17Co-InfectionsNone
DLS0083204Hepatitis C (HCV) Genotype 1ItalySerum1.0010.00$95.0078 YMWhite<-70C22-Mar-18Roche cobas4,000,000 IU/mLHCV Viral LoadGenotype1b12-Jan-183-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsFatigueAdditional TestingBilirubin: 0.5 mg/dL | Creatinine: 0.9 mg/dL | Chronic Hepatitis C12-Jan-18Hepatitis SerologyHBsAg- | HBsAb+ | HBcAb+ | (CMIA)12-Jan-18Co-InfectionsNone
DLS0025514Hepatitis C (HCV) Genotype 1ItalySerum1.008.00$95.0053 YMWhite<-70C23-Jan-18Roche cobas13,200,000 IU/mLHCV Viral LoadGenotype1b27-May-173-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingALT: 108 U/L | AST: 56 U/L | Bilirubin: 0.76 mg/dL | Chronic Hepatitis C23-Jan-18Hepatitis SerologyHBsAg- | HBsAb+ | HBcAb+ | (CMIA)27-May-17Co-InfectionsNone
DLS0025507Hepatitis C (HCV) Genotype 1ItalySerum1.0012.00$95.0066 YFWhite<-70C08-Mar-18Roche cobas90,560 IU/mLHCV Viral LoadGenotype1b10-Feb-163-series HepB VaccineNo$95.00Acquired Infection CategoryTransfusionIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingALT: 103 U/L | AST: 55.5 U/L | Bilirubin: 1.5 mg/dL | Creatinine: 1.0 mg/dL | Chronic Hepatitis C3-Feb-18Hepatitis SerologyHBsAg- | HBsAb- | HBcAb- | (CMIA)10-Jan-18Co-InfectionsNone
DLS0083205Hepatitis C (HCV) Genotype 1ItalySerum1.0012.00$95.0048 YFWhite<-70C05-Apr-18Roche cobas12,500,000 IU/mLHCV Viral LoadGenotype1b9-Feb-183-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingBilirubin: 0.5 mg/dL | Creatinine: 0.6 mg/dL | Chronic Hepatitis C9-Feb-18Hepatitis SerologyHBsAg- | HBsAb- | HBcAb+ | (CMIA)9-Feb-18Co-InfectionsNone
DLS0025503Hepatitis C (HCV) Genotype 1ItalySerum1.0014.00$95.0061 YFWhite<-70C08-Mar-18Roche cobas227 IU/mLHCV Viral LoadGenotype1b10-Feb-173-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsFatigueAdditional TestingALT: 73 U/L | AST: 103 U/L | Bilirubin: 1.5 mg/dL | Creatinine: 1.1 mg/dL | Chronic Hepatitis C4-Mar-18Hepatitis SerologyHBsAg- | HBsAb- | HBcAb- | (CMIA)6-Dec-17Co-InfectionsNone
DLS0083211Hepatitis C (HCV) Genotype 1ItalySerum1.0012.00$95.0065 YMWhite<-70C08-May-18Roche cobas1,190,000 IU/mLHCV Viral LoadGenotype1b26-Mar-183-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingBilirubin: 1.04 mg/dL | Creatinine: 0.8 mg/dL | Chronic Hepatitis C14-Mar-18Hepatitis SerologyHBsAg- | HBsAb- | HBcAb+ | (CMIA)14-Mar-18Co-InfectionsNone
DLS0083210Hepatitis C (HCV) Genotype 1ItalySerum1.0013.00$95.0033 YFWhite<-70C02-May-18Roche cobas541,300 IU/mLHCV Viral LoadGenotype1a15-Mar-183-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingBilirubin: 0.3 mg/dL | Creatinine: 0.77 mg/dL | Chronic Hepatitis C15-Mar-18Hepatitis SerologyHBsAg- | HBsAb+ | HBcAb+ | (CMIA)15-Mar-18Co-InfectionsNone
DLS0083206Hepatitis C (HCV) Genotype 1ItalySerum1.0012.00$95.0070 YFWhite<-70C09-Apr-18Roche cobas1,000,000 IU/mLHCV Viral LoadGenotype1b21-Nov-173-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingALT: 36.4 U/L | AST: 34.5 U/L | Bilirubin: 0.95 mg/dL | Creatinine: 0.65 mg/dL | Chronic Hepatitis C21-Mar-18Hepatitis SerologyHBsAg- | HBsAb- | HBcAb- | (CMIA)21-Mar-18Co-InfectionsNone
DLS0083207Hepatitis C (HCV) Genotype 1ItalySerum1.0013.00$95.0070 YMWhite<-70C13-Apr-18Roche cobas290,000 IU/mLHCV Viral LoadGenotype1b13-Sep-173-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingBilirubin: 0.7 mg/dL | Creatinine: 0.9 mg/dL | Chronic Hepatitis C26-Mar-18Hepatitis SerologyHBsAg- | HBsAb- | HBcAb- | (CMIA)6-Apr-18Co-InfectionsNone
DLS0025517Hepatitis C (HCV) Genotype 1ItalySerum1.005.00$95.0058 YMWhite<-70C15-Mar-18Roche cobas470,000 IU/mLHCV Viral LoadGenotype1b3-Jan-173-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingBilirubin: 0.6 mg/dL | Creatinine: 0.8 mg/dL | Chronic Hepatitis C27-Mar-18Hepatitis SerologyHBsAg- | HBsAb- | HBcAb- | (CMIA)26-Jan-18Co-InfectionsNone
DLS0083208Hepatitis C (HCV) Genotype 1ItalySerum1.007.00$95.0057 YMWhite<-70C18-Apr-18Roche cobas212 IU/mLHCV Viral LoadGenotype1a5-Jun-173-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingBilirubin: 0.78 mg/dL | Creatinine: 1.0 mg/dL | Chronic Hepatitis C9-Apr-18Hepatitis SerologyHBsAg- | HBsAb+ | 6-Nov- (CMIA)2017Co-InfectionsNone
DLS0083209Hepatitis C (HCV) Genotype 1ItalySerum1.0010.00$95.0070 YFWhite<-70C27-Apr-18Roche cobas9,550,000 IU/mLHCV Viral LoadGenotype1a15-Jan-183-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingBilirubin: 0.7 mg/dL | Creatinine: 0.6 mg/dL | Chronic Hepatitis C20-Apr-18Hepatitis SerologyHBsAg- | HBsAb+ | HBcAb+ | (CMIA)15-Jun-17Co-InfectionsNone
DLS0083214Hepatitis C (HCV) Genotype 1ItalySerum1.0013.00$95.0071 YFWhite<-70C12-Jun-18Roche cobas7,980,000 IU/mLHCV Viral LoadGenotype1b10-Jan-183-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsFatigueAdditional TestingBilirubin: 1.8 mg/dL | Creatinine: 0.7 mg/dL | Chronic Hepatitis C30-May-18Hepatitis SerologyHBsAg- | HBsAb+ | HBcAb- | (CMIA)10-Jan-18Co-InfectionsNone
DLS0083218Hepatitis C (HCV) Genotype 1ItalySerum1.0013.00$95.0076 YFWhite<-70C26-Jul-18Roche cobas6,000,000 IU/mLHCV Viral LoadGenotype1b31-May-183-series HepB VaccineNo$95.00Acquired Infection CategoryU/AIs Subject on Anti-Viral Therapy / TreatmentNoCurrent SymptomsNo symptomsAdditional TestingALT: 230 U/L | AST: 200 U/L | Bilirubin: 2.76 mg/dL | Creatinine: 0.9 mg/dL | Chronic Hepatitis C22-Jun-18Hepatitis SerologyHBsAg- | HBsAb- | CMIA)31-May-18Co-InfectionsNone

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.